Skeletal system disorder
MONDO:0005172A disease involving the skeletal system.
Also known as: disease of skeletal system, disease or disorder of skeletal system, disorder of skeletal system, skeletal system disease, skeletal system disease or disorder, disease of bone and/or joint, osteoarthropathy
9167 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 3193 trials in this tab.
-
Personalized chemo and transplants aim to beat infant leukemia
⭐️ CURE ⭐️ Recruiting nowThis phase 2 trial tests whether adjusting chemotherapy and using stem cell transplants based on each infant's genetic profile can improve survival. Infants under one year old with newly diagnosed leukemia receive a risk-stratified treatment plan. The study aims to see if this pe…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: ⭐️ CURE ⭐️
Last updated Jul 31, 2026 00:00 UTC
-
Can a smarter surgery and antibiotic combo cure joint infections for good?
⭐️ CURE ⭐️ Recruiting nowThis trial compares different surgical and antibiotic approaches to treat infections in artificial hip and knee joints. It tests whether cleaning the joint while keeping the implant in place (DAIR) or replacing the joint entirely leads to better cure rates. It also examines wheth…
Phase: PHASE4 • Sponsor: University of Newcastle, Australia • Aim: ⭐️ CURE ⭐️
Last updated Jul 29, 2026 00:00 UTC
-
Supercharged donor cells aim to stop leukemia return after transplant
⭐️ CURE ⭐️ Recruiting nowThis study tests a new approach to prevent leukemia from coming back after a stem cell transplant. It uses donor T cells that have been engineered to recognize and attack a specific target (HA-2) on leukemia cells. The trial enrolls adults with acute myeloid leukemia (AML) or mye…
Phase: PHASE3 • Sponsor: TScan Therapeutics, Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
Can a Two-Drug combo outsmart a deadly leukemia?
⭐️ CURE ⭐️ Recruiting nowThis trial is testing whether adding bortezomib to standard chemotherapy (CPX-351) can improve outcomes for people with a newly diagnosed, aggressive form of acute myeloid leukemia that has a TP53 mutation. The study aims to find a safe dose and see if the combination leads to mo…
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: ⭐️ CURE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Can a hyaluronic acid gel help Smokers' gums heal better?
Disease control Recruiting nowThis study tests whether adding hyaluronic acid gel to standard deep-cleaning treatment improves gum healing in smokers with advanced periodontitis. Twenty-three smokers will receive the standard cleaning, then some gum pockets will also get the gel. Researchers will measure gum …
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New transplant cocktail aims to tame blood cancer without severe side effects
Disease control Recruiting nowThis early-stage trial is testing a new combination of chemotherapy drugs (thiotepa, busulfan, and fludarabine) followed by a stem cell transplant for people with certain blood cancers like leukemia and myelodysplastic syndrome. The goal is to see if this approach can reduce the …
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New study tests secukinumab for back pain patients in korea
Disease control Recruiting nowThis study follows 70 Korean adults with ankylosing spondylitis who have never taken biologic drugs. They will receive secukinumab as part of routine care. Researchers will measure changes in disease activity and inflammation over time to see how effective the treatment is in rea…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New hope for rare blood cancers: pacritinib trial opens for teens and adults
Disease control Recruiting nowThis study tests an oral drug called pacritinib in people aged 12 and older with myelodysplastic syndromes (MDS) or related blood cancers (MDS/MPN). The goal is to find the best dose and see if it can shrink or control the disease. Participants take capsules twice daily for up to…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Can a diabetes drug ease knee pain and stave off surgery?
Disease control Recruiting nowThis trial tests whether adding metformin, a common diabetes medication, to a program of diet and exercise can reduce knee pain and improve function in overweight or obese adults with knee osteoarthritis. Participants will receive either metformin or a placebo for six months, alo…
Phase: EARLY_PHASE1 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Can a tropical tea shrink blood cancers?
Disease control Recruiting nowThis pilot study tests whether drinking tea made from soursop leaves can reduce the number of cancer cells in people with relapsed or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) — blood cancers that have not responded to standard treatments. About 20 particip…
Phase: EARLY_PHASE1 • Sponsor: Roger Strair • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Ear zap may tame inflammation after spine surgery
Disease control Recruiting nowThis study tests whether a non-invasive device that gently stimulates a nerve in the ear can lower inflammation and pain after major spine surgery. About 50 adults having long-segment spinal fusion will be randomly assigned to receive the stimulation or standard care. Researchers…
Phase: NA • Sponsor: Alexander T. Yahanda • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New hope for leukemia patients? early trial launches
Disease control Recruiting nowThis early-phase study tests a new drug (ICP-248) combined with a standard medicine (azacitidine) in people with acute myeloid leukemia or myelodysplastic syndromes. The goal is to find a safe dose and see if the combo helps control the disease. About 266 adults who have not resp…
Phase: PHASE1 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New drug pacritinib takes on standard therapy for rare leukemia
Disease control Recruiting nowThis phase 2 trial compares pacritinib to the standard drug hydroxyurea in 66 adults with advanced proliferative chronic myelomonocytic leukemia (CMML). The goal is to see if pacritinib improves blood cell counts, reduces spleen size, and controls symptoms better than hydroxyurea…
Phase: PHASE2 • Sponsor: Theradex • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New hope for Tough-to-Treat leukemia: multiple drug cocktails tested
Disease control Recruiting nowThis phase II trial tests several experimental drug combinations against the standard treatment for high-risk acute myeloid leukemia (AML) in patients aged 59 or younger. The goal is to see if newer regimens, including venetoclax and liposome formulations, can better shrink cance…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Can a Skin-Derived graft match the gold standard for saving molars?
Disease control Recruiting nowThis trial tests two surgical techniques for repairing furcation defects—areas where bone loss has occurred between the roots of lower molars—in people with advanced periodontitis. One method uses a graft derived from donated skin (acellular dermal matrix), while the other uses a…
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Engineered immune cells take on sarcoma in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called attIL12-TIL for people with advanced or metastatic soft tissue and bone sarcoma. The therapy uses a patient's own tumor-fighting immune cells, modified to better target and attack cancer. The study first finds a safe dose, then …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Wisdom tooth graft showdown: donor vs. Patient's own dentin
Disease control Recruiting nowThis study tests whether a donor tooth-derived bone graft works as well as a patient's own tooth graft for preserving jawbone after impacted wisdom tooth extraction. Forty adults with similar impacted wisdom teeth on both sides of the jaw will receive one graft type per side. Res…
Phase: NA • Sponsor: Horus University • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Can a smart stimulator restore hand function after spinal cord injury?
Disease control Recruiting nowThis trial tests whether a non-invasive spinal cord stimulation device that turns on and off based on muscle signals can improve hand and arm function in people with spinal cord injury. Participants will receive both closed-loop stimulation (which responds to their own muscle act…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New combo therapy aims to boost remission in IDH2-Mutated AML
Disease control Recruiting nowThis phase II trial tests whether adding enasidenib to standard ASTX727 and venetoclax improves remission rates in older adults (or younger unfit patients) with newly diagnosed IDH2-mutated acute myeloid leukemia (AML). About 93 participants will be randomly assigned to receive e…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New combo pill aims to shrink spleens and ease symptoms in bone marrow cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding pelabresib to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a type of bone marrow cancer. About 460 adults who have not taken JAK inhibitors before will receive either the combination or a …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
Can a new injection tame overactive blood cell production?
Disease control Recruiting nowThis early-stage trial is testing an investigational drug called BEBT-507 in adults with polycythemia vera, a condition where the body makes too many red blood cells. The study aims to find a safe dose and see if the drug can help control blood cell levels, potentially reducing t…
Phase: PHASE1 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 19, 2026 08:00 UTC
-
New hope for young AML patients: targeted drug combo tested in phase 2 trial
Disease control Recruiting nowThis study tests two different drug combinations for younger adults with a specific type of acute myeloid leukemia (CBF-AML). One group gets standard chemotherapy plus a targeted antibody, while the other gets the same chemotherapy plus a newer targeted pill. The goal is to see w…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can patients stop Anti-Rejection drugs sooner after transplant?
Disease control Recruiting nowThis study tests whether patients can safely stop the drug tacrolimus earlier than usual after a stem cell transplant. Tacrolimus is given to prevent graft-versus-host disease (GVHD), but newer methods have lowered GVHD risk. The trial will enroll 50 people with blood cancers and…
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Less neck surgery may spare shoulder function in oral cancer patients
Disease control Recruiting nowThis study tests whether a less invasive surgery called sentinel lymph node biopsy can replace standard neck dissection for early-stage oral cavity cancer. About 686 patients will be randomly assigned to one of the two procedures. The goal is to see if the gentler approach mainta…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can an ancient herbal remedy tame rheumatoid arthritis?
Disease control Recruiting nowThis study tests whether adding a Chinese herbal formula (Si Miao Xiao Bi Tang) to standard rheumatoid arthritis medication can improve symptoms. About 132 adults with active RA will receive either the herbal medicine or a placebo for 12 weeks. The main goal is to see if more peo…
Phase: PHASE2, PHASE3 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Talking through pain: could counseling unlock better exercise for knee arthritis?
Disease control Recruiting nowThis trial tests whether adding motivational interviewing—a counseling style that strengthens personal motivation—to a standard exercise program helps people with knee osteoarthritis feel more confident about exercising and managing pain. About 56 participants will be randomly as…
Phase: NA • Sponsor: Kutahya Health Sciences University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New triple therapy aims to boost survival in frail AML patients
Disease control Recruiting nowThis phase 3 trial will test whether adding the drug quizartinib to the standard two-drug combination (venetoclax and azacitidine) helps adults with newly diagnosed acute myeloid leukemia (AML) live longer. The study includes 376 people aged 18 and older who cannot receive intens…
Phase: PHASE3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a smartphone app replace physiotherapy for knee pain?
Disease control Recruiting nowThis trial tests whether a smartphone app-guided rehabilitation program (MOKneeTOR) is as effective as traditional hospital-based physiotherapy for people with knee osteoarthritis. Participants will be randomly assigned to either use the app for 24 weeks or attend outpatient phys…
Phase: NA • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn leukemia
Disease control Recruiting nowThis early-phase trial is testing a new cell therapy called CD83 CAR T cells in 26 adults with acute myeloid leukemia (AML) that has returned or not responded to treatment. The therapy uses a patient's own immune cells, genetically modified to recognize and attack a protein (CD83…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug FOG-001 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug, FOG-001, in about 595 people with advanced or metastatic solid tumors, including colorectal, prostate, and liver cancers. The drug is given alone or with other cancer treatments to see if it is safe and shrinks tumors. The study is cu…
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can gum surgery permanently fix a gummy smile?
Disease control Recruiting nowThis study looks at whether a type of gum surgery called esthetic crown-lengthening can provide lasting results for people with a gummy smile caused by altered passive eruption. Ten adults with excessive gingival display will undergo the procedure, which involves removing excess …
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Electric jolt workouts: a new hope for paralyzed limbs?
Disease control Recruiting nowThis study tests whether exercise using electrical stimulation can improve muscle strength and endurance in people with lower limb paralysis from conditions like spinal cord injury, stroke, or multiple sclerosis. Participants will use devices that send electrical signals to their…
Phase: NA • Sponsor: Louis Stokes VA Medical Center • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy aims to improve AML treatment for patients with specific gene changes
Disease control Recruiting nowThis early-phase trial tests whether adding a menin inhibitor (SNDX-5613) to standard chemotherapy can better control acute myeloid leukemia (AML) in people with certain gene changes (NPM1 or MLL). About 38 newly diagnosed adults will receive the combination to find the safest do…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug aims to stop immune attack after stem cell transplants
Disease control Recruiting nowThis study tests a drug called BPC2001 to prevent acute graft-versus-host disease (aGVHD), a serious complication where donor immune cells attack the patient's body after a stem cell transplant. Fifty adults with blood cancers like leukemia will receive six weekly doses of BPC200…
Phase: PHASE2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo aims to keep childhood leukemia at bay after transplant
Disease control Recruiting nowThis phase 1 trial tests the safety and best dose of an oral drug called ASTX727 (a combination of cedazuridine and decitabine) along with filgrastim in children with high-risk acute myeloid leukemia (AML) that has returned or not responded to treatment. All participants have alr…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New shot aims to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study tests a drug called AGA2115 in 80 adults with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. Participants receive either the drug or a placebo as a shot under the skin. The main goal is to see if the drug increases bone density in the spine after 1…
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can gentler therapy beat harsh chemo for tough leukemia?
Disease control Recruiting nowThis phase 3 trial tests whether less intense drug combinations can control relapsed or refractory acute myeloid leukemia (AML) as well as high-dose chemotherapy. About 339 adults whose AML has returned or not responded to initial treatment will be randomly assigned to either a l…
Phase: PHASE3 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for AML patients: Triple-Drug combo targets Tough-to-Treat leukemia
Disease control Recruiting nowThis study tests whether adding pivekimab sunirine to the standard drugs venetoclax and azacitidine helps adults with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. About 660 participants will be randomly assigned to receive ei…
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for AML patients in india: drug combo aims for remission without intensive chemo
Disease control Recruiting nowThis study tests a combination of two drugs, venetoclax and azacitidine, in about 100 adults in India with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The goal is to see if the combo can put the cancer into remissio…
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for leukemia patients: asciminib trial launches
Disease control Recruiting nowThis Phase 2 trial tests the drug asciminib in 50 adults newly diagnosed with chronic myeloid leukemia (CML). The goal is to see if asciminib can control the disease and to check for side effects. Participants take the drug by mouth, and researchers monitor their health closely.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Mind over movement: Brain-Controlled therapy aims to restore walking after spinal injury
Disease control Recruiting nowThis study tests a new therapy that uses a brain-computer interface to detect when a person tries to move, then activates spinal cord stimulation to help them walk. It is for people with incomplete spinal cord injury who are at least 6 months post-injury. The goal is to see if it…
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for kids with tough leukemia: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study is testing an experimental drug called pivekimab sunirine in about 18 children whose acute myeloid leukemia (AML) has come back or not responded to standard treatments. The main goals are to check the drug's safety and how it moves through the body. Partici…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can trained immune cells stop blood cancer relapse?
Disease control Recruiting nowThis trial tests whether giving patients special immune cells, called TAA-T, after a stem cell transplant can help prevent high-risk blood cancers like acute myeloid leukemia from coming back. The cells are designed to recognize three common tumor markers and attack any remaining…
Phase: PHASE1 • Sponsor: Catherine Bollard • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Gene therapy may free gaucher patients from lifelong infusions
Disease control Recruiting nowThis Phase 3 trial tests a gene therapy called FLT201 for adults with Gaucher disease type 1. The goal is to see if a single dose can keep blood counts stable so patients can stop their regular enzyme replacement or substrate reduction therapy. The study will enroll 45 people who…
Phase: PHASE3 • Sponsor: Spur Therapeutics • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Blood-Derived clot may regrow bone in gum disease
Disease control Recruiting nowThis trial compares two surgical approaches for treating furcation defects—bone loss where tooth roots split—in adults with periodontitis. One group receives a mix of advanced platelet-rich fibrin (A-PRF+) and bone graft material, while the other gets a collagen membrane with the…
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new pill boost the power of an existing leukemia treatment?
Disease control Recruiting nowThis trial is testing whether an experimental drug called PBSS1113, taken as a pill alongside the standard medicine azacitidine, can help people with acute myeloid leukemia (AML) or a related condition called myelodysplastic syndrome (MDS). The study includes adults who have eith…
Phase: PHASE1, PHASE2 • Sponsor: Chaser Therapeutics, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New pill hopes to tame rare childhood brain diseases
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called nizubaglustat (AZ-3102) in people aged 4 and older with Niemann-Pick type C disease, GM1 gangliosidosis, or GM2 gangliosidosis. The study lasts 18 months and compares the drug to a placebo to see if it is safe and can slow disease prog…
Phase: PHASE3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New pill aims to keep blood cancer away after transplant
Disease control Recruiting nowThis study tests a daily pill called olutasidenib given after a stem cell transplant to people with certain blood cancers (like AML or MDS) that have an IDH1 mutation. The goal is to see if the drug is safe and tolerable as maintenance therapy. About 31 participants will take the…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a gut microbiome transplant ease axial spondyloarthritis?
Disease control Recruiting nowThis trial tests whether transferring gut bacteria from a healthy donor (fecal microbiota transplantation, or FMT) can reduce disease activity in people with axial spondyloarthritis (axSpA) who haven't fully responded to biologic therapy. Participants receive a single enema with …
Phase: PHASE2 • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could controlled Low-Oxygen breathing prevent dangerous blood pressure swings in spinal injury?
Disease control Recruiting nowThis study tests whether breathing a low-oxygen gas mixture (mild intermittent hypoxia) can help prevent blood pressure problems in people with spinal cord injuries. The 24 participants will have motor-incomplete injuries above the 12th thoracic vertebra and signs of autonomic dy…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New pill could ease severe childhood arthritis
Disease control Recruiting nowThis study tests a new oral medication, upadacitinib, in children aged 1 to 17 with active systemic juvenile idiopathic arthritis (sJIA), a rare and serious form of arthritis that can affect the whole body. About 90 participants will receive either upadacitinib or the standard in…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New shoulder implant tracked for 10 years in 300 patients
Disease control Recruiting nowThis study is testing a shoulder replacement device in 300 people with shoulder arthritis, bone death, or rotator cuff tears. Participants receive the implant and are followed for 10 years to see how well it works and if it is safe. The goal is to improve pain and shoulder functi…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New pill could help control blood disorder when standard drugs fail
Disease control Recruiting nowThis study tests a new drug called flonoltinib maleate in 60 people with polycythemia vera (a condition where the body makes too many red blood cells) who cannot take or no longer respond to standard treatments. The goal is to see if the drug safely reduces red blood cell levels …
Phase: PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
No drill, no shot: new study tests easier crowns for Kids' teeth
Disease control Recruiting nowThis study will test a gentler way to fix cavities in children's permanent molars using the Hall Technique, which places a stainless steel crown without drilling or numbing shots. Ten children will get either the Hall Technique or the standard method (with drilling and anesthesia…
Phase: NA • Sponsor: Latakia University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New pill aims to shrink spleen in bone marrow cancer
Disease control Recruiting nowThis phase 3 trial tests a new drug called flonoltinib maleate in people with intermediate- or high-risk myelofibrosis, a type of bone marrow cancer. The study compares flonoltinib to an existing drug, ruxolitinib, to see if it can reduce spleen size and improve symptoms. About 1…
Phase: PHASE3 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a Bone-Sparing hip implant outperform traditional replacement?
Disease control Recruiting nowThis trial tests whether a new type of hip resurfacing implant, called the H1, can be as successful as a standard total hip replacement for people with hip arthritis. Participants will receive either the H1 implant or a traditional replacement, and researchers will compare their …
Phase: NA • Sponsor: Embody Orthopaedic Limited • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for myelofibrosis patients who failed standard therapy
Disease control Recruiting nowThis study tests an experimental drug called flonoltinib maleate in about 64 people with a rare bone marrow cancer (myelofibrosis) that is moderate to high risk and has not responded to or stopped responding to standard JAK inhibitor therapy. Participants take a daily pill on an …
Phase: PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Engineered t cells target hidden leukemia cells in new trial
Disease control Recruiting nowThis phase I trial tests a new treatment for adults with acute myeloid leukemia (AML) who have minimal residual disease (MRD) — small amounts of cancer cells that remain after standard therapy. The treatment uses the patient's own T cells, genetically modified to recognize a prot…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can one injection beat back pain? a trial aims to find out
Disease control Recruiting nowThis trial investigates different types of steroid injections for back, neck, and related pain to see which are most effective and safe. It compares various steroids, doses, and injection sites, including epidural and facet joint injections. The study measures pain relief and fun…
Phase: PHASE4 • Sponsor: Igor Wilderman. MD • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill could transform leukemia treatment, phase 3 trial begins
Disease control Recruiting nowThis study tests a new oral drug, QTX-2101, combined with standard ATRA therapy for adults newly diagnosed with a low-risk form of acute promyelocytic leukemia (APL). The goal is to see if the oral capsule works as well as the current intravenous treatment. About 150 participants…
Phase: PHASE3 • Sponsor: Quetzal Therapeutics • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new gum graft technique fully cover exposed roots after braces?
Disease control Recruiting nowThis trial compares two surgical techniques for treating receding gums in people who have completed orthodontic treatment. Participants receive a coronally advanced flap combined with either a de-epithelialized soft tissue graft or a subepithelial connective tissue graft. The goa…
Phase: PHASE2, PHASE3 • Sponsor: Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a simpler dental procedure spare kids from a painful root canal?
Disease control Recruiting nowThis trial tests whether a simpler dental procedure called pulpotomy works as well as the standard pulpectomy for treating severe tooth decay in children's baby molars. Pulpotomy removes only the infected part of the pulp and seals it, while pulpectomy removes the entire pulp and…
Phase: NA • Sponsor: Qatar University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New combo aims for deeper remission in older leukemia patients
Disease control Recruiting nowThis phase II trial tests whether adding gilteritinib to the usual two-drug therapy (azacitidine and venetoclax) can help older or frail adults with a specific type of acute myeloid leukemia (FLT3-mutated) achieve deeper remission. About 147 participants will be randomly assigned…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for leukemia patients: targeted therapy aims to eliminate hidden cancer cells
Disease control Recruiting nowThis study tests whether a targeted drug called gemtuzumab ozogamicin can clear tiny amounts of leukemia that remain after initial treatment in adults with acute myeloid leukemia (AML). The drug works like a smart bomb, attaching to a protein on cancer cells and delivering a chem…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can saving the meniscus save knees from osteoarthritis?
Disease control Recruiting nowThis study follows 300 people with a specific type of knee injury called a displaced bucket-handle meniscus tear, which can lock the knee and damage the joint. Researchers will compare two surgical approaches: repairing the torn meniscus with stitches versus removing the damaged …
Sponsor: Region Skane • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can reduce the need for blood transfusions and increase red blood cell levels. The study is in earl…
Phase: PHASE1, PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Immune booster shot aims to speed recovery after cord blood transplant
Disease control Recruiting nowThis early-phase trial tests whether injecting special immune progenitor cells (HTLPs) can help the immune system recover faster after a cord blood transplant in adults with blood cancers. Ten participants will receive the injection alongside their transplant. The goal is to see …
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Mouthwash showdown: can a new formula fight gum disease without staining teeth?
Disease control Recruiting nowThis study tests whether a chlorhexidine mouthwash with an anti-discoloration system (ADS) can prevent gum inflammation better than a placebo. Healthy volunteers will stop brushing for three weeks and use only the mouthwash to see how well it controls plaque and gingivitis. The g…
Phase: NA • Sponsor: University of Bern • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for tough leukemia? early trial of debio 1562M begins
Disease control Recruiting nowThis early-phase trial is testing a new drug called Debio 1562M in about 134 people with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The study first checks safety and finds the right dose, then looks at whether the drug can shrink the can…
Phase: PHASE1, PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a new toothpaste tame gum disease?
Disease control Recruiting nowThis study tests whether an experimental toothpaste containing stannous fluoride can reduce gum inflammation and plaque buildup better than a standard fluoride toothpaste. About 110 adults with mild to moderate gingivitis will brush twice daily for 8 weeks. Researchers will measu…
Phase: NA • Sponsor: HALEON • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for psoriatic arthritis sufferers: experimental drug sonelokimab enters final testing phase
Disease control Recruiting nowThis study tests a new drug called sonelokimab for adults with active psoriatic arthritis who have not improved with or cannot take standard TNF-blocker medications. About 600 participants will receive either sonelokimab, a placebo, or an existing drug (risankizumab) for comparis…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new shoulder implant restore Pain-Free movement?
Disease control Recruiting nowThis study follows 60 adults who receive a total shoulder replacement using the PRIMA humeral stem, either in an anatomic or reverse configuration. The goal is to measure changes in shoulder function, pain, and quality of life over 24 months, as well as how well the implant holds…
Sponsor: Limacorporate S.p.a • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Old drug, new hope: niclosamide tested for tough childhood leukemia
Disease control Recruiting nowThis early-phase trial tests niclosamide, a drug previously used for tapeworm infections, combined with standard chemotherapy in 16 children whose acute myeloid leukemia (AML) has returned or not responded to treatment. The main goal is to find a safe dose and check for side effe…
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New cell therapy HN2301 enters human trials for autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new therapy, HN2301, in 30 adults with lupus, scleroderma, or rheumatoid arthritis. The main goal is to check safety and find the right dose. Researchers will also look for early signs that the treatment helps control the disease by measuring immune…
Phase: PHASE1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New CML drug asciminib under Real-World study
Disease control Recruiting nowThis study is watching how well asciminib works and how safe it is in adults with a type of blood cancer called chronic myeloid leukemia. It includes people who are newly diagnosed or have already tried one other treatment. The main goal is to see how many patients reach a very l…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a Two-Drug combo tame a rare blood cancer?
Disease control Recruiting nowThis trial is testing whether combining two drugs, pacritinib and azacitidine, can help people with chronic myelomonocytic leukemia (CMML), a rare blood cancer. The study includes adults who are newly diagnosed or have had limited prior treatment. The goal is to find the safest d…
Phase: PHASE1, PHASE2 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Weekly shot could replace daily growth hormone for kids
Disease control Recruiting nowThis phase 3 trial compares a once-weekly growth hormone injection (lonapegsomatropin) to a daily one (somatropin) in 186 prepubertal children with growth failure due to Turner syndrome, SHOX deficiency, being small for gestational age, or idiopathic short stature. The goal is to…
Phase: PHASE3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis pain in major trial
Disease control Recruiting nowThis Phase 3 trial tests whether the experimental drug zasocitinib (TAK-279) can reduce joint swelling and pain in people with active psoriatic arthritis. About 600 adults will receive either the drug or a placebo for up to 60 weeks. The main goal is to see if more people on the …
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New combo therapy aims to beat back relapsed leukemia after transplant
Disease control Recruiting nowThis phase 2 trial tests whether combining interferon-gamma (a protein that boosts the immune system) with donor immune cells can help patients whose acute myeloid leukemia or myelodysplastic syndromes have returned after a stem cell transplant. The study will enroll 45 adults an…
Phase: PHASE2 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New combo therapy for rare blood cancers put on hold
Disease control Recruiting nowThis phase 2 trial compares a drug combo (ASTX727 plus iadademstat) against ASTX727 alone for people with advanced myeloproliferative neoplasms (MPNs), a group of rare blood cancers. The study aims to see if adding iadademstat improves complete response rates. However, the trial …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a targeted drug boost chemo success in leukemia?
Disease control Recruiting nowThis phase II trial is testing whether adding the drug venetoclax to standard chemotherapy can improve remission rates in younger patients with intermediate-risk acute myeloid leukemia (AML). About 153 participants will receive either standard chemo or a combination with venetocl…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a Tumor-Injected drug combo outlast standard care in advanced sarcoma?
Disease control Recruiting nowThis phase 3 trial is testing whether an investigational drug called INT230-6, which combines three anti-cancer agents and is injected directly into tumors, can help people with advanced soft tissue sarcoma live longer than those receiving standard care. The study enrolls adults …
Phase: PHASE3 • Sponsor: Intensity Therapeutics, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a targeted drug boost transplant success for tough blood cancers?
Disease control Recruiting nowThis clinical trial is testing whether adding the drug venetoclax to standard chemotherapy before a stem cell transplant can improve outcomes for people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The study will enroll 324 participants and aims …
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a robotic horse improve scoliosis therapy?
Disease control Recruiting nowThis trial tests whether adding horse riding simulator sessions to standard core exercises helps teenagers with scoliosis. Participants use the simulator twice a week for 12 weeks, alongside supervised exercises. Researchers will measure changes in balance, breathing strength, qu…
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a once-every-few-weeks IV infusion tame rheumatoid arthritis?
Disease control Recruiting nowThis study tests whether giving sarilumab (Kevzara) through an IV with longer intervals between doses is safe and works well for adults with moderate-to-severe rheumatoid arthritis. Participants receive the drug intravenously, with or without other standard arthritis medications.…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis without biologics
Disease control Recruiting nowThis Phase 3 study tests whether the oral drug zasocitinib (TAK-279) can improve symptoms of active psoriatic arthritis in people who have never used biologic treatments. About 1,088 adults will receive either zasocitinib, an active comparator, or a placebo for up to 60 weeks. Th…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New antibody drug takes aim at rheumatoid arthritis in first human trial
Disease control Recruiting nowThis early-stage trial tests a new drug called KT502 in 27 adults with moderate to severe rheumatoid arthritis. The drug is designed to deplete certain immune cells (B cells) that contribute to joint inflammation. The main goal is to check safety and find the right dose, not yet …
Phase: PHASE1 • Sponsor: Kali Therapeutics, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug combo aims to control rare blood cancer in High-Risk patients
Disease control Recruiting nowThis study tests a combination of two drugs, azacitidine and enasidenib, in people with a high-risk blood cancer called myelodysplastic syndrome (MDS) that has a specific genetic change (IDH2 mutation). The goal is to see if the drugs can stop cancer growth and improve outcomes. …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a tailored chemo cocktail outsmart a common leukemia?
Disease control Recruiting nowThis trial is testing whether a chemotherapy combination called HAD, given at intermediate doses, works better than the standard regimen for people with a specific genetic subtype of acute myeloid leukemia (AML) known as CEBPA double-mutated. The study enrolls adults aged 14 to 5…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Bone drug tested to shield young transplant survivors from fractures
Disease control Recruiting nowThis early study tests whether giving a bone-strengthening drug called zoledronate soon after a stem cell transplant can safely prevent bone loss and fractures in children. Researchers will enroll 20 children aged 5 to 18 who are at high risk for bone problems. The goal is to see…
Phase: PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can diabetes drugs tame joint inflammation in psoriatic arthritis?
Disease control Recruiting nowThis trial asks whether GLP-1 medications, commonly used for type 2 diabetes and weight loss, can better control psoriatic arthritis symptoms than nutrition counseling alone. Adults with psoriatic arthritis who also have obesity and type 2 diabetes will be randomly assigned to re…
Phase: PHASE4 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug tulisokibart aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new medicine called tulisokibart for people with active psoriatic arthritis, a condition causing joint pain and skin plaques. Researchers will compare different doses of the drug to a placebo in 140 adults to see if it improves symptoms like joint tenderness an…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug HC-7366 tested for tough leukemia
Disease control Recruiting nowThis early-phase trial is testing a new drug called HC-7366 in 18 adults with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The main goal is to find a safe dose and check for side effects. Researchers hope this drug may offer a new option f…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for kids with arthritis: Long-Term drug study launches
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of the drug filgotinib in children and adolescents aged 8 to 17 with juvenile idiopathic arthritis. Participants must have already completed a previous filgotinib study and shown improvement. The goal is to see if the d…
Phase: PHASE3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a simple pill improve recovery after hip replacement?
Disease control Recruiting nowThis study tests whether taking oral tranexamic acid for three days after hip replacement surgery can reduce pain, swelling, and help patients walk sooner. About 101 adults with end-stage osteoarthritis will receive the drug or placebo. The goal is to see if this simple pill impr…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Lung-Directed chemo spray aims to stop cancer spread
Disease control Recruiting nowThis study tests a procedure called pulmonary suffusion, which delivers the chemotherapy drug cisplatin directly to the lungs through a minimally invasive method. The goal is to control any remaining cancer cells after surgery or ablation in patients with sarcoma or colorectal ca…
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a stem cell shot rebuild Worn-Out knees?
Disease control Recruiting nowThis study tests an experimental stem cell injection called FURESTEM-OA-Kit in people with knee osteoarthritis who previously received a placebo in an earlier trial. The goal is to see if the injection is safe and can improve knee pain, stiffness, and function. Participants will …
Sponsor: Kang Stem Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for kids with tough leukemia: targeted drugs added to chemo
Disease control Recruiting nowThis study tests whether adding dasatinib or venetoclax to standard chemotherapy can help more children with T-cell acute lymphoblastic leukemia or lymphoma achieve a deep remission. About 100 children and young adults aged 1 to 18 will receive one of these targeted drugs alongsi…
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a simple pill stabilize blood pressure after spinal cord injury?
Disease control Recruiting nowThis trial compares two blood pressure medications—midodrine and droxidopa—against compression stockings and a placebo to see which best stabilizes blood pressure in people with spinal cord injury. Participants have a traumatic injury between C1 and T6, are at least a year post-i…
Phase: PHASE4 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can green tea gel help heal gum pockets?
Disease control Recruiting nowThis trial tests whether a gel made from green tea extract (EGCG) can improve the treatment of stage II periodontitis, a moderate form of gum disease. Thirty adults with gum pockets will receive either the gel or a placebo gel, injected into the gums after standard deep cleaning.…
Phase: PHASE1 • Sponsor: Mansoura University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug aims to tame immune system in lupus and Sjogren's
Disease control Recruiting nowThis early-stage trial tests an investigational drug called ABBV-319 in 36 adults with lupus or Sjogren's disease. The drug is designed to deplete overactive B cells, which are part of the immune system that cause inflammation and symptoms. Participants receive two doses by IV, 2…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New pill shows promise for rare joint tumor in early trial
Disease control Recruiting nowThis phase 2 trial tests a daily oral drug called pimicotinib in 20 Japanese adults with tenosynovial giant cell tumor (TGCT) that cannot be removed by surgery. The study aims to see if the drug is safe, how it moves through the body, and whether it shrinks tumors. Participants t…
Phase: PHASE2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can targeted drug cocktails erase hidden leukemia cells?
Disease control Recruiting nowThis trial is testing whether combining various chemotherapy and targeted drugs can clear measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) who are in remission but still have traces of leukemia cells. The study enrolls patients aged 14 and older with …
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can new drug cocktails beat back Hard-to-Treat leukemia?
Disease control Recruiting nowThis trial is testing several different drug combinations to find the best approach for people with acute myeloid leukemia (AML) that has not responded to treatment or has come back. The study compares the effectiveness and safety of these salvage therapies, aiming to improve rem…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a blood-derived patch strengthen cleft palate repair?
Disease control Recruiting nowThis trial compares standard cleft palate surgery alone versus surgery augmented with platelet-rich fibrin (PRF) or gentamicin-loaded PRF in 90 children and adolescents with cleft palates. The goal is to see if these biological adjuncts improve wound healing, reduce wound breakdo…
Phase: NA • Sponsor: Al-Thawra Modern General Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a cancer drug fix a bleeding disorder and prevent leukemia?
Disease control Recruiting nowThis early-stage trial tests imatinib, a drug already used for certain cancers, in adults with a harmful RUNX1 gene mutation. The mutation causes easy bleeding and a high risk of blood cancers. The study aims to find the best dose and see if imatinib can improve platelet function…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Spine disc injection could ease back pain without surgery
Disease control Recruiting nowThis Phase 3 trial tests whether a single injection of IDCT (rebonuputemcel), a cell therapy, can safely reduce pain and disability in people with mild to moderate lumbar disc degeneration. About 162 adults with chronic low back pain will receive either the cell injection or a sh…
Phase: PHASE3 • Sponsor: DiscGenics, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New triple therapy offers hope for AML patients
Disease control Recruiting nowThis study tests a new combination of three drugs (venetoclax, azacitidine, and liposomal mitoxantrone) as the first treatment for adults with newly diagnosed acute myeloid leukemia (AML). About 30 participants will receive this therapy, followed by standard chemotherapy and, for…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Experimental drug TURALIO takes on tough childhood cancers in early trial
Disease control Recruiting nowThis early-phase study tests the drug TURALIO (pexidartinib) in people aged 3 to 35 whose cancer has not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors or control leukemia. Participants take a daily capsule for up to 2 years, wit…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Promising new combo therapy for infant leukemia shows potential
Disease control Recruiting nowThis study tests whether adding two targeted drugs, blinatumomab and venetoclax, to standard chemotherapy can improve outcomes for infants with a type of leukemia called acute lymphoblastic leukemia (ALL). About 153 infants will participate. The goal is to see if these combinatio…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo aims to tame tough autoimmune diseases
Disease control Recruiting nowThis study tests two medications, inebilizumab and blinatumomab, in adults with active lupus (with kidney inflammation) or hard-to-treat rheumatoid arthritis. The goal is to see if these drugs are safe and can help control the diseases. About 220 people will take part. This is no…
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for kids with arthritis: baricitinib Long-Term trial underway
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of the drug baricitinib for children aged 1 to 17 with juvenile idiopathic arthritis (JIA). It includes 190 participants who have already taken baricitinib in a previous study. Researchers will monitor side effects and ho…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New combo therapy aims to tame leukemia without lifelong pills
Disease control Recruiting nowThis study tests whether combining dasatinib with ropeginterferon can better control chronic myeloid leukemia in its early phase. About 40 adults newly diagnosed with CML will receive the drug pair to see if it improves disease control and reduces side effects. The goal is to man…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Higher chemo dose may boost survival in rare leukemia subtype
Disease control Recruiting nowThis Phase 3 trial is testing whether a higher dose of the chemotherapy drug cytarabine, given with standard drugs, improves survival for people with acute myeloid leukemia (AML) that has a specific genetic change called RUNX1-RUNX1T1. The study will enroll 300 adults aged 14 to …
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can less be more? trial tests cutting RA medication doses
Disease control Recruiting nowThis trial asks whether people with rheumatoid arthritis who have low disease activity can safely reduce their JAK inhibitor dose without losing control of their symptoms. Participants will either follow a step-by-step dose-tapering plan or continue their usual full-dose medicati…
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a pill tackle Tough-to-Treat leukemia?
Disease control Recruiting nowThis study tests an experimental oral medicine called CHM-029 in adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments, and that carries specific genetic changes (NPM1 mutations or KMT2A/NUP98 rearrangements). The main goals are to fin…
Phase: PHASE1 • Sponsor: Charm Therapeutics • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Supercharged immune cells take on tough blood cancers
Disease control Recruiting nowThis study tests a new treatment for people with blood cancers like leukemia, lymphoma, and multiple myeloma that have returned or not responded to treatment. Participants receive chemotherapy followed by specially engineered natural killer (NK) cells from donated cord blood. The…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Immune cell therapy takes on autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment called NKX019 for people with autoimmune diseases like systemic sclerosis, rheumatoid arthritis, and vasculitis. NKX019 uses specially engineered immune cells to target and calm overactive B cells that cause the disease. The goal is to see if it i…
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could less be more? new trial shortens leukemia drug course for seniors
Disease control Recruiting nowThis study looks at whether giving the drug venetoclax for a shorter time, along with the combination drug ASTX727, works as well as the usual longer course for adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for strong chemot…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for kids with psoriatic arthritis: apremilast trial begins
Disease control Recruiting nowThis Phase 3 study tests whether the drug apremilast (Otezla) can safely reduce joint inflammation and pain in children aged 5 to 17 with active juvenile psoriatic arthritis. About 60 participants will receive either apremilast or a placebo pill for 16 weeks. The main goal is to …
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Hope for rare bone disease: first drug trial launches
Disease control Recruiting nowThis study tests a new drug called PTH-IA for Jansen's Metaphyseal Chondrodysplasia (JMC), a very rare genetic disorder that causes severe bone problems, short stature, and kidney issues. About 12 adults and children will receive the drug to see if it is safe and works. The goal …
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo aims to improve leukemia treatment before transplant
Disease control Recruiting nowThis study is for adults with a certain type of acute myeloid leukemia (AML) who are in remission and planning a stem cell transplant. It compares a combination of two drugs, venetoclax and azacitidine, against standard high-dose chemotherapy as a 'consolidation' step before the …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug INCA035784 enters human testing for rare blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug, INCA035784, in 120 adults with myeloproliferative neoplasms (a group of blood cancers). The main goal is to check safety and find the right dose. Participants must have a specific genetic mutation (CALR) and have tried other treatments bef…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a targeted pill boost chemo for tough blood cancer?
Disease control Recruiting nowThis Phase 3 trial tests whether adding the drug venetoclax to standard chemotherapy helps adults with newly diagnosed acute myeloid leukemia (AML) or a related high-risk condition. About 650 participants aged 18 to 75 will receive either venetoclax or a placebo alongside chemo. …
Phase: PHASE3 • Sponsor: University of Ulm • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New knee implant aims for 10-Year durability in arthritis patients
Disease control Recruiting nowThis study is testing the LEGION Medial Stabilized knee implant in 144 people who need total knee replacement due to arthritis or joint damage. The goal is to see how well the implant holds up over 10 years without needing revision surgery. Participants will receive one of three …
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill could boost leukemia treatment for patients with specific gene changes
Disease control Recruiting nowThis phase 3 trial tests whether adding the drug bleximenib to standard chemotherapy helps adults with a certain genetic type of acute myeloid leukemia (AML). About 875 people will get either bleximenib or a placebo alongside chemo, then be followed for 4 years. The goal is to se…
Phase: PHASE3 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Experimental CAR t therapy targets tough childhood leukemia
Disease control Recruiting nowThis early-phase trial is testing a new type of immune cell therapy called FOLR1 CAR T cells for children aged 6 and under with acute myeloid leukemia (AML) that has come back or not responded to treatment. The therapy involves taking a child's own immune cells, modifying them in…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a single Anti-Inflammatory injection boost jaw joint relief?
Disease control Recruiting nowThis trial tests whether adding a single injection of the anti-inflammatory drug meloxicam to a standard jaw joint washout procedure (arthrocentesis) improves outcomes for people with painful jaw joint problems. Half of the 50 adult participants will receive the combined treatmen…
Phase: NA • Sponsor: Hussein Mohammed Ridha • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for rare blood cancer: targeted drug enters final testing
Disease control Recruiting nowThis study tests a new drug, INCA033989, against the best current treatments for people with a rare blood cancer called essential thrombocythemia who have a specific gene mutation (CALR). About 426 adults who have already tried at least one prior therapy will be randomly assigned…
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug karonudib tested in blood cancer patients
Disease control Recruiting nowThis early-phase trial tests the safety of a new drug called karonudib in up to 9 adults with blood cancers like leukemia who have no standard treatment options left. The study aims to find a safe dose and look for any signs that the drug works. It is too early to know if karonud…
Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug aims to halt lung damage in autoimmune patients
Disease control Recruiting nowThis study tests whether the drug nerandomilast can slow lung scarring in people with autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults whose lung function hasn't improved with standard treatment will take either nerandomilast or a placebo twice daily…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a simple wash save a tooth that hurts?
Disease control Recruiting nowThis trial tests whether using calcium hypochlorite or sodium hypochlorite to clean the pulp wound during a partial pulpotomy can improve the success of saving painful, deeply decayed permanent molars. Adults aged 18-40 with symptomatic irreversible pulpitis will undergo the proc…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Stem cell gel could offer new hope for knee arthritis sufferers
Disease control Recruiting nowThis Phase 3 trial tests whether a gel made from donated umbilical cord stem cells (CARTISTEM) can reduce pain and improve knee function better than a simple surgical cleanup (debridement) in people with knee cartilage damage and osteoarthritis. About 300 adults aged 18-75 with m…
Phase: PHASE3 • Sponsor: Medipost, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Which surgery unlocks a locked jaw? a Head-to-Head test
Disease control Recruiting nowThis trial compares two surgical techniques for treating a painful jaw condition called disc displacement without reduction, where the jaw's cushioning disc slips out of place and limits mouth opening. Participants will receive either arthroscopic lysis and lavage, a procedure th…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Gene therapy injection takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests a single-dose gene therapy called VNX-101 for people with certain blood cancers (like leukemia or lymphoma) that have returned or not responded to standard treatment. The therapy delivers instructions to the body to make a protein that helps immune ce…
Phase: PHASE1, PHASE2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called NT-175 for people with advanced solid tumors (like lung, colon, or breast cancer) that have a specific mutation (TP53 R175H) and a certain immune marker (HLA-A*02:01). NT-175 is made from a patient's own immune cells, which are …
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Jaw pain surgery showdown: which arthroscopic technique wins?
Disease control Recruiting nowThis trial compares two arthroscopic procedures for treating painful jaw joint disc displacement with reduction. One procedure involves rinsing the joint and releasing adhesions, while the other adds further tissue adjustment. The study will see which method better improves mouth…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo aims to keep High-Risk leukemia in remission before transplant
Disease control Recruiting nowThis study tests whether a combination of venetoclax and azacitidine works better than standard chemotherapy to keep high-risk acute myeloid leukemia (AML) from coming back before a stem cell transplant. About 216 adults who have already achieved remission after initial treatment…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Promising drug combo may stop painful flare-ups in rare bone disease
Disease control Recruiting nowThis study looks at whether anti-inflammatory drugs (like anakinra or canakinumab) can reduce painful flare-ups and prevent extra bone growth in people with a rare genetic condition called fibrodysplasia ossificans progressiva (FOP). Eleven people with severe FOP will be tracked …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug aims to cut blood removal in rare cancer
Disease control Recruiting nowThis trial tests rusfertide, an injected drug, in Japanese adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal is to see if rusfertide can keep red blood cell levels under control and reduce the need for phlebotomy (blood removal). Al…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Microembolization may outlast steroid shots for frozen shoulder
Disease control Recruiting nowThis study compares two treatments for frozen shoulder: a newer procedure called transcatheter arterial microembolization (TAME) and standard corticosteroid injections. TAME aims to reduce pain by blocking abnormal blood vessels in the shoulder, while steroids work by calming inf…
Phase: NA • Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug combo aims to beat back relapsed leukemia
Disease control Recruiting nowThis study tests a new chemotherapy drug, L-Annamycin, combined with standard cytarabine in adults with acute myeloid leukemia (AML) that has come back or not responded to first treatment. About 312 participants will receive either the new drug combo or a placebo plus cytarabine.…
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug aims to ease anemia in bone marrow cancer patients
Disease control Recruiting nowThis Phase 3 trial tests whether elritercept can improve anemia in people with myelofibrosis who are already taking ruxolitinib. About 324 participants will receive either elritercept or a placebo for at least 9 months. The main goal is to see if the drug reduces the need for red…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Botox for jaw pain: a shot at rewiring pain signals?
Disease control Recruiting nowThis study tests whether botulinum toxin (Botox) injections into the jaw muscle can reduce pain and alter pain-related gene activity in people with painful jaw disorders. Half of the 100 participants receive Botox, the other half a placebo (saline). Researchers compare pain level…
Phase: PHASE2 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Experimental drug plus radiation aims to tackle returning head and neck cancers
Disease control Recruiting nowThis early-phase trial is testing whether a drug called camonsertib, combined with a precise type of radiation, can help control head and neck cancers that have come back or cannot be removed by surgery. About 39 adults with these cancers will receive the drug along with focused …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New hope for rare sarcomas: chemo plus immunotherapy combo enters phase III trial
Disease control Recruiting nowThis Phase III trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (doxorubicin) helps people with advanced dedifferentiated liposarcoma or undifferentiated pleomorphic sarcoma live longer without their cancer worsening. About 365 adults whose…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can donor immune cells fight leukemia relapse after transplant?
Disease control Recruiting nowThis early-phase trial is testing whether infusing natural killer (NK) cells from a healthy donor, combined with low-dose interleukin-2 (IL-2), can safely help treat acute myeloid leukemia (AML) that has returned after a stem cell transplant. The study involves about 12 adults wi…
Phase: PHASE1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can two common drugs tame rheumatoid arthritis?
Disease control Recruiting nowThis phase 2 trial tests whether adding either diosmin or rebamipide to standard rheumatoid arthritis treatment can better reduce disease activity and improve physical function. About 66 adults with active rheumatoid arthritis will be split into three groups: one receiving standa…
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New Bacteria-Based therapy tested for leukemia relapse prevention
Disease control Recruiting nowThis early-stage trial tests a new treatment called QUAIL-100, made from a live weakened bacteria, in children and young adults with high-risk leukemia or myelodysplastic syndrome who have already had a stem cell transplant. The main goal is to check safety and side effects. Only…
Phase: PHASE1 • Sponsor: Laguna Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can insulin help heal gums? a trial puts it to the test
Disease control Recruiting nowThis trial tests whether applying insulin or hyaluronic acid gel directly into gum pockets, alongside standard deep cleaning, improves healing in people with stage III periodontitis. About 45 adults with gum disease will receive one of the two gels or cleaning alone, and research…
Phase: EARLY_PHASE1 • Sponsor: Doaa Atta Aid • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New antibody GEN3018 enters first human tests for tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new antibody drug called GEN3018 in people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has come back or stopped responding to treatment. The main goal is to check safety and find the right dose. Up to 78 parti…
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New inhaled drug aims to stop lung infections in vulnerable blood cancer patients
Disease control Recruiting nowThis study tests an experimental inhaled drug called PUL-042 in 100 people with blood cancers or who have had a stem cell transplant and have a viral lung infection. Participants receive either the drug or a placebo three times over six days. The goal is to see if PUL-042 can red…
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThis study tests whether an investigational drug called PLG0206 can prevent infections from coming back after knee replacement surgery. About 240 adults who need a special cleaning surgery (DAIR) for an infected knee joint will receive either PLG0206 or a placebo during the proce…
Phase: PHASE2, PHASE3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted pill boost standard therapy for hard-to-treat leukemia?
Disease control Recruiting nowThis phase 3 trial is testing whether adding revumenib, a drug that blocks a protein called menin, to the usual two-drug combination (azacitidine and venetoclax) can improve outcomes for adults newly diagnosed with acute myeloid leukemia (AML) that has a specific genetic change (…
Phase: PHASE3 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New pill shows promise for rare bone marrow cancer
Disease control Recruiting nowThis study tests an experimental pill called nuvisertib for people with myelofibrosis, a rare bone marrow disorder. It is for patients whose disease is moderate to high risk and who have not responded well to standard treatments. The goal is to see if the drug is safe and can shr…
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New injection aims to tame rheumatoid arthritis
Disease control Recruiting nowThis early-stage trial is testing a new biologic drug called plamotamab in 68 adults with moderate to severe rheumatoid arthritis (RA) who haven't gotten enough relief from other treatments. The drug is given as a shot under the skin, and the main goal is to see if it's safe and …
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New daily pill shows promise for Long-Term psoriatic arthritis control
Disease control Recruiting nowThis study tests the long-term safety and effectiveness of an oral drug called zasocitinib (TAK-279) in adults with active psoriatic arthritis, a condition causing joint pain and skin patches. About 1,182 participants who completed a one-year parent study will take either a lower…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New neck implant under study: will it ease pain and improve lives?
Disease control Recruiting nowThis study is tracking 200 adults who receive the Ennovate Cervical Spinal System, a metal implant used to stabilize the neck and upper back after fractures, disc disease, or tumors. Researchers will measure changes in pain and quality of life over time. The goal is to confirm th…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return
Disease control Recruiting nowThis study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Arthritis drug xeljanz XR under Real-World watch in korea
Disease control Recruiting nowThis study tracks the safety and effectiveness of the arthritis drug Xeljanz XR in about 200 adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Participants take the drug as prescribed by their doctor, and researchers record any s…
Sponsor: Pfizer • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a brace and targeted exercises ease spondylolisthesis pain?
Disease control Recruiting nowThis study tests whether wearing a soft back brace for several weeks, combined with either stabilization or conventional exercises, can reduce pain, improve physical function, and boost quality of life in adults with spondylolisthesis. Participants are adults aged 18-65 with mild…
Phase: NA • Sponsor: Medipol University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for kids with relapsed leukemia: experimental drug combo enters safety trial
Disease control Recruiting nowThis early-stage study tests whether adding a new drug called revumenib to two standard chemotherapy drugs is safe for children and young adults whose acute myeloid leukemia (AML) has not responded to treatment or has returned. The study involves 24 participants and aims to find …
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New study tracks xeljanz safety in kids with arthritis
Disease control Recruiting nowThis study looks at the safety and effectiveness of the drug Xeljanz in children aged 2 to 17 with active juvenile idiopathic arthritis or juvenile psoriatic arthritis. It is an observational study in Korean clinics, meaning doctors prescribe the drug as usual and researchers mon…
Sponsor: Pfizer • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Which biologic is best for nasal polyps? new study aims to find out
Disease control Recruiting nowThis study will compare three FDA-approved biologic drugs (dupilumab, omalizumab, and mepolizumab) in 504 adults with chronic sinusitis and nasal polyps. The goal is to see which drug works best for different patients and whether simple tests can predict who will improve the most…
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a Triple-Drug combo tame acute myeloid leukemia in frail patients?
Disease control Recruiting nowThis phase 2 trial is testing whether adding an experimental drug called MAX-40279 to the standard combination of venetoclax and azacitidine can help treat newly diagnosed acute myeloid leukemia (AML) in people who are not healthy enough for intensive chemotherapy. The study incl…
Phase: PHASE2 • Sponsor: Maxinovel Pty., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New trial aims to solve JIA treatment puzzle after first drug fails
Disease control Recruiting nowThis study is for children aged 2 to 17 with polyarticular juvenile idiopathic arthritis (JIA) whose first TNF inhibitor medication did not work well enough. It compares three different non-TNFi drugs (abatacept, tocilizumab, tofacitinib) against a second TNF inhibitor to see whi…
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a smart brain implant outsmart chronic pain?
Disease control Recruiting nowThis trial tests whether a new type of deep brain stimulation (DBS) can better relieve chronic pain that hasn't responded to other treatments. Unlike traditional DBS, which delivers constant stimulation, this approach uses a device that adapts stimulation in real time based on br…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a gentler gum treatment change the chemical signature of periodontitis?
Disease control Recruiting nowThis trial compares two non-surgical approaches for treating periodontitis: a minimally invasive technique (MINST) and a quadrant-by-quadrant deep cleaning (Q-SI). Researchers will measure changes in gum pocket depth and analyze the chemical makeup of fluid from the gums before a…
Phase: NA • Sponsor: University of Catania • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can 3D printing precision redefine denture comfort?
Disease control Recruiting nowThis trial tests whether different 3D printing angles and layer thicknesses affect how accurately dentures fit and how satisfied patients are. Adults aged 50 to 70 with no teeth will each receive two 3D-printed upper dentures made with the same angle but different thicknesses, in…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a vitamin d boost strengthen bones and mobility after neurological injury?
Disease control Recruiting nowThis trial is testing whether vitamin D supplements can improve bone density, body composition, strength, walking speed, and physical performance in people hospitalized with neurological disorders like stroke, spinal cord injury, or traumatic brain injury. Participants will recei…
Phase: NA • Sponsor: Dionyssiotis, Yannis, M.D. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Electrical implant aims to restore movement after paralysis
Disease control Recruiting nowThis study tests an implanted electrical stimulation device designed to improve movement, standing, and walking in people with paralysis from spinal cord injury, stroke, multiple sclerosis, or traumatic brain injury. The device sends electrical signals to muscles in the trunk and…
Phase: NA • Sponsor: Louis Stokes VA Medical Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a VR headset straighten Teens' posture?
Disease control Recruiting nowThis trial tests whether virtual reality-based posture training, using a Meta Quest 3 headset, can improve the spine curvature (kyphotic angle) and quality of life in adolescents aged 13 to 18 with thoracic hyperkyphosis (a rounded upper back). Participants will receive a 12-week…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Which thumb arthritis surgery works best? a Head-to-Head trial aims to find out
Disease control Recruiting nowThis trial compares three common surgical procedures for thumb basal joint arthritis: trapeziectomy with ligament reconstruction, trapeziectomy with suture suspensionplasty, and arthroscopic trapeziectomy alone. The goal is to see which technique best restores grip and pinch stre…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can barbed sutures improve healing in obese neck surgery patients?
Disease control Recruiting nowThis trial investigates whether barbed sutures are a safe and effective way to close deep tissue incisions in obese patients undergoing posterior cervical spine surgery. Researchers will measure changes in spinal function, neck disability, and pain levels, as well as monitor for …
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a tailored surgical approach improve outcomes for spinal stenosis?
Disease control Recruiting nowThis study tests whether a precise, individualized version of a common spinal surgery can safely improve function and reduce pain in people with cervical spinal stenosis. Researchers will compare outcomes in 500 patients who receive the standardized open-door procedure with a tit…
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Blood-Derived shot may mend Worn-Out knees
Disease control Recruiting nowThis trial tests whether injections of platelet-rich plasma (PRP) — a concentrate from a person's own blood — can repair knee osteoarthritis and injuries to cartilage, meniscus, and ligaments. Researchers will compare PRP against standard hyaluronic acid injections in 300 adults …
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Spine surgery secrets: opening angle may determine recovery
Disease control Recruiting nowThis study looks at how the angle of the opened bone and other surgical details affect recovery in people with cervical spinal stenosis who undergo a single open-door surgery. Researchers will review records from 500 patients across multiple centers to see which factors lead to b…
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Personalized maintenance therapy: a smarter way to treat advanced cancer?
Disease control Recruiting nowThis phase II trial is testing whether continuing targeted therapy or immunotherapy based on a tumor's molecular profile can benefit patients with advanced solid tumors that have stopped responding to prior treatment. After an initial treatment period, patients whose disease is s…
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a common antibiotic beat MRSA in kids? a trial puts TMP-SMX to the test
Disease control Recruiting nowThis trial compares two oral antibiotics—trimethoprim-sulfamethoxazole (TMP-SMX) and clindamycin—to see which works better for children with invasive MRSA infections, such as bone, joint, or deep tissue infections. About 100 children aged 60 days to 18 years will take one of the …
Phase: PHASE4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Blood concentrate may supercharge gum repair — a trial puts it to the test
Disease control Recruiting nowThis trial tests whether adding injectable platelet-rich fibrin (I-PRF) — a concentrate made from a patient's own blood — to standard minimally invasive gum cleaning can improve healing of deep periodontal defects. About 48 adults with advanced gum disease and at least one deep p…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a simple dental procedure save teeth with extremely deep cavities?
Disease control Recruiting nowThis study compares a dental procedure called direct pulp capping for two types of deep cavities in adult molars: deep and extremely deep. The goal is to see if the treatment works equally well for both, measuring success by tooth survival, lack of pain, and healing on X-rays. Pa…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A new ligament-tethering technique may spare spine patients from fusion surgery
Disease control Recruiting nowThis trial tests whether a novel surgical technique called vertebropexy—which uses a donor ligament to stabilize the spine—can match or outperform standard decompression or fusion surgery for degenerative lumbar spinal disease. The study enrolls adults needing single- or two-leve…
Phase: NA • Sponsor: Balgrist University Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Tooth enamel regrown with a gel? a new trial explores a drill-free fix for early decay.
Disease control Recruiting nowThis pilot trial tests a gel called Epinamel that aims to regrow tooth enamel naturally by using minerals from saliva. It includes 20 people who just had their braces removed and have white spot lesions—early signs of decay—on both sides of their mouth. The gel is applied to one …
Phase: NA • Sponsor: Mintech Bio Ltd • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a targeted pill stall advanced sarcomas?
Disease control Recruiting nowThis phase II trial is testing whether abemaciclib, a targeted cancer drug, can slow the growth of advanced bone and soft tissue sarcomas that have a specific alteration in the CDK pathway. Participants take the pill twice daily until their disease worsens or side effects become …
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Nanoparticle steroid spray could transform recovery after sinus surgery
Disease control Recruiting nowThis trial tests a new nanoparticle spray containing the steroid triamcinolone acetonide for people recovering from endoscopic sinus surgery. The spray is designed to deliver the drug directly to the nasal cavity to reduce inflammation and improve healing. Researchers compare it …
Phase: PHASE2 • Sponsor: Deraya University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a pomegranate peel gel boost gum healing?
Disease control Recruiting nowThis trial tests whether a gel made from pomegranate peel extract, placed directly into deep gum pockets after a standard deep cleaning, can improve healing in people with moderate to advanced gum disease (periodontitis). Thirty-two adults will receive the gel on one side of the …
Phase: NA • Sponsor: gehad samy • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Spinal stimulation may reawaken paralyzed arms — a trial puts it to the test
Disease control Recruiting nowThis trial investigates whether a surgically implanted device that delivers personalized electrical stimulation to the spinal cord can improve upper limb function in people with spinal cord injury. Twenty participants with injuries at or above the T4 level will receive the implan…
Phase: NA • Sponsor: Buddhist Tzu Chi General Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a thermosensitive gel help gums heal better after deep cleaning?
Disease control Recruiting nowThis trial tests whether a gel made from hyaluronic acid and octenidine, placed into deep gum pockets, can improve healing after standard deep cleaning (scaling and root planing) for periodontitis. About 40 adults with moderate to severe gum disease will receive the gel on one si…
Phase: NA • Sponsor: University of Bologna • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Spinal cord zap may help people breathe again after neck injury
Disease control Recruiting nowThis trial tests whether a device that sends mild electrical pulses to the spinal cord can help people with a cervical spinal cord injury breathe more independently. Twenty adults with a C1-C5 injury who need a ventilator will have electrodes implanted near the injury site and re…
Phase: NA • Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a Two-Pronged pill outsmart stubborn leukemia?
Disease control Recruiting nowThis early-stage trial is testing an experimental oral drug, HPB-092, in people whose acute myeloid leukemia (AML) has returned or not responded to standard treatments. The drug is designed to block two proteins, FLT3 and IRAK4, that help leukemia cells grow and survive. The stud…
Phase: PHASE1 • Sponsor: Hangzhou Polymed Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a traditional chinese herb tame stubborn rheumatoid arthritis?
Disease control Recruiting nowThis trial investigates whether adding Kunxian Capsule, a traditional Chinese herbal remedy, to standard medications (methotrexate and tofacitinib) can improve outcomes for people with refractory rheumatoid arthritis — a form that does not respond well to usual treatments. About …
Phase: PHASE4 • Sponsor: Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a strip of your own gum plus donor tissue rebuild healthier gums?
Disease control Recruiting nowThis trial tests whether combining a thin strip of the patient's own gum tissue with a donor tissue matrix can improve the quality and amount of keratinized gum tissue around teeth and dental implants. Twenty adults with thin or missing gum tissue will receive one of two surgical…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
A gel that may save the tooth next door: wisdom tooth extraction gets a preventive upgrade
Disease control Recruiting nowThis trial tests whether applying a regenerative gel called Emdogain to the root of the second molar during wisdom tooth removal can prevent the deep pockets and bone loss that often develop on that tooth afterward. The study involves 70 healthy adults who need a lower wisdom too…
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a Follow-Up drug keep bones strong after initial osteoporosis therapy?
Disease control Recruiting nowThis study looks at postmenopausal women with severe osteoporosis who have finished a course of either romosozumab or teriparatide. Researchers want to see which follow-up drug—zoledronate, denosumab, teriparatide, romosozumab, or abaloparatide—best maintains or improves bone den…
Sponsor: 424 General Military Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Experimental biologic CND319 takes first steps toward taming autoimmune diseases
Disease control Recruiting nowThis early-stage study tests an experimental drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's syndrome. The main goal is to check safety and how the body processes the drug. Researchers will also look for early signs that it might help co…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Thinking your way to movement: brain-computer interface tested for hand function in tetraplegia
Disease control Recruiting nowThis trial tests whether an implantable brain-computer interface (BCI) can help people with tetraplegia from spinal cord injury regain hand function. Participants receive a surgically implanted BCI that reads brain signals and controls pneumatic gloves to assist with grasping and…
Phase: NA • Sponsor: NeuroXess Technology (shanghai) Co.,Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Healing heel bone infections: could an antibiotic bone graft be the key?
Disease control Recruiting nowThis trial tests whether adding an antibiotic-impregnated bone graft substitute (Cerament G) to standard surgery improves healing of heel bone infections (calcaneal osteomyelitis) in people with diabetes. Thirty participants will be randomly assigned to receive either partial rem…
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Robot-Assisted knee surgery tests custom alignment for Longer-Lasting implants
Disease control Recruiting nowThis trial tests two ways of aligning a new knee joint during robotic surgery: the traditional mechanical alignment that keeps the leg straight, and a personalized kinematic alignment that matches the patient's natural anatomy. Researchers will track how well the implant stays in…
Phase: NA • Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Flexible spine tether could offer Motion-Saving alternative to fusion for scoliosis
Disease control Recruiting nowThis study follows about 100 children with progressive idiopathic scoliosis who undergo vertebral body tethering surgery using the Tether™ device. The goal is to track safety and how well the device keeps the spine straight over time. Participants are skeletally immature with mod…
Sponsor: LDR Médical SAS • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Tendon pain showdown: which injection works better?
Disease control Recruiting nowThis study compares two types of injections—hyaluronic acid and platelet-rich plasma (PRP)—for treating chronic tendon pain, such as Achilles tendinopathy and golfer's elbow. Eighty adults with pain lasting over three months will receive two injections, two weeks apart, and be fo…
Phase: NA • Sponsor: Ortonika Orthopedic Medical Clinic in Lublin • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New Triple-Drug strategy aims to boost remission in Hard-to-Treat leukemia
Disease control Recruiting nowThis phase 3 trial tests whether combining the targeted drug venetoclax with either a short course of decitabine or a modified DA regimen (daunorubicin and cytarabine) works better than the standard 3+7 DA regimen for adults newly diagnosed with acute myeloid leukemia. About 291 …
Phase: PHASE3 • Sponsor: The Second Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a simple injection dissolve painful calcium lumps in rare diseases?
Disease control Recruiting nowThis study tests whether injecting sodium thiosulfate directly into abnormal calcium deposits can shrink them and reduce pain. It includes people with three rare conditions: systemic sclerosis, dermatomyositis, and a genetic disorder called iPPSD2. Participants receive up to 11 i…
Phase: PHASE2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a simple breathing device help children speak more clearly without surgery?
Disease control Recruiting nowThis study tests whether a handheld device that strengthens the muscles used for breathing and swallowing can improve speech in children aged 5 to 17 with velopharyngeal dysfunction, a condition where the soft palate does not close properly, causing nasal-sounding speech. Partici…
Phase: NA • Sponsor: Noel Jabbour • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Electric jolts to abdominal muscles may restore cough power after spinal injury
Disease control Recruiting nowThis study investigates whether combining electrical stimulation of the abdominal and back muscles with specific breathing exercises can improve the strength of an unaided cough in people with acute spinal cord injury. Participants will use a device called the Xcite system to del…
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Which RA drug works best after the first one fails? a major trial aims to find out
Disease control Recruiting nowThis study compares two treatment strategies for people with active rheumatoid arthritis (RA) who have already tried a type of biologic called a TNF inhibitor. Participants are randomly assigned to switch to either a different class of biologic (non-TNFi) or a newer oral medicati…
Phase: PHASE3 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Massive AML trial aims to find best chemo and transplant protection for younger patients
Disease control Recruiting nowThis study tests different chemotherapy doses and a drug to prevent graft-versus-host disease in adults aged 18 to 60 with newly diagnosed acute myeloid leukemia. Participants receive either idarubicin or daunorubicin during initial chemo, followed by high or intermediate doses o…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail aims to outperform standard immunotherapy in bile duct cancer
Disease control Recruiting nowThis phase 3 trial tests whether a combination of two experimental drugs (futibatinib and zimberelimab) plus standard chemotherapy can help people with advanced biliary tract cancer live longer compared to current standard immunotherapy combinations. The study enrolls about 784 a…
Phase: PHASE3 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Eggshells vs. fluoride: can a kitchen scrap beat standard cavity care?
Disease control Recruiting nowThis trial tests whether a varnish made from nano-sized eggshell can help reverse the earliest stage of tooth decay (enamel caries) in adolescents aged 15-20. It compares the eggshell varnish against two established treatments: a CPP-ACP paste (GC Tooth Mousse) and a standard 5% …
Phase: NA • Sponsor: Mansoura University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a Dual-Action pill tame the tumor behind cushing disease?
Disease control Recruiting nowThis phase 2 trial tests fimepinostat, a drug that blocks two cancer-related pathways, in adults with Cushing disease caused by a pituitary tumor. The goal is to see if the drug can lower cortisol levels to normal within four weeks. The study compares two doses and includes patie…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Ancient oil pulling gets a modern test against plaque and gingivitis
Disease control Recruiting nowThis study tests whether an oil pulling mouthwash can reduce dental plaque, gum inflammation, and harmful bacteria better than a standard mouthwash or a placebo rinse. Healthy adults aged 18 to 70 with mild to moderate gum inflammation will use one of three rinses for a period. R…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gum disease showdown: platelet gel, laser, or iodine – which works best?
Disease control Recruiting nowThis study tests three add-on treatments for gum disease: a platelet-rich fibrin gel (I-PRF), a diode laser, and an iodine rinse. Each is used alongside standard deep cleaning in smokers and non-smokers with moderate to severe periodontitis. The goal is to see which approach best…
Phase: PHASE4 • Sponsor: Military Hospital of Tunis • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Hip muscle repair method may improve walking after bone cancer surgery
Disease control Recruiting nowThis trial compares two surgical methods for reattaching the hip abductor muscles after proximal femur replacement, a surgery often needed for bone cancer or metastases. The goal is to see which method leads to better walking and hip function. Researchers will also test a simple …
Sponsor: Duke University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New filling material that fights cavities could change how Kids' teeth are repaired
Disease control Recruiting nowThis study tests a newer filling material called Cention-N against standard composite resin for repairing cavities in children's first permanent molars. Cention-N releases minerals that may help prevent further decay. One hundred children aged 8-10 with similar cavities on both s…
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could adding pilates to schroth exercises boost lung and muscle function in teens with scoliosis?
Disease control Recruiting nowThis study investigates whether adding Pilates-based exercises to standard Schroth training improves lung capacity, trunk muscle strength, posture, and quality of life in adolescents with idiopathic scoliosis. Participants, aged 10-18 with a spinal curve between 10 and 45 degrees…
Phase: NA • Sponsor: Ankara Yildirim Beyazıt University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Antibiotic-Releasing bone graft aims to fight infection and regrow bone in one step
Disease control Recruiting nowThis trial tests a special bone graft that releases the antibiotic tobramycin to treat infected knee replacements. The graft is placed during the first stage of revision surgery, with the goal of clearing the infection and promoting new bone growth. About 200 adults with infected…
Phase: NA • Sponsor: Elute, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Antibiotic-Infused bone graft could slash infection risk in hip replacements
Disease control Recruiting nowThis trial investigates whether adding antibiotics (vancomycin and tobramycin) to bone graft material during hip replacement surgery can reduce the risk of serious joint infections. The study includes adults undergoing hip replacement who need bone graft, comparing those who rece…
Phase: PHASE2 • Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Glow-in-the-Mouth rinse could catch cavities before they start
Diagnosis Recruiting nowThis study tests whether a fluorescent starch nano-particle mouth rinse, combined with saliva biomarkers, can detect the earliest stages of tooth decay more accurately than a traditional visual exam. Sixty adults with at least one suspected early enamel lesion will be evaluated u…
Phase: NA • Sponsor: Menoufia University • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Back pain or blocked arteries? new study aims to tell them apart
Diagnosis Recruiting nowThis study will check how common peripheral artery disease (PAD) is in people who need surgery for lumbar spinal stenosis (LSS). Both conditions can cause leg pain, making PAD hard to spot. Researchers will use a special CT scan to find PAD and compare it with simpler tests like …
Phase: NA • Sponsor: Rennes University Hospital • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Ultrasound and EMG may tell inflammatory from mechanical shoulder issues
Diagnosis Recruiting nowThis study compares muscle thickness around the shoulder blade in people with early ankylosing spondylitis (an inflammatory condition) versus those with mechanical shoulder blade movement problems. Researchers use ultrasound and electromyography (EMG) to see if they can tell the …
Sponsor: Tanta University • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Can a simple blood test catch Cushing's earlier?
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose Cushing's syndrome, a condition caused by too much cortisol. Researchers will test the accuracy of the desmopressin stimulation test in 140 people aged 18-70 who have or may have Cushing's, plus healthy volunteers. Participants will…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Glowing dye could help surgeons remove sarcomas in one go
Diagnosis Recruiting nowThis study tests whether a dye called indocyanine green can help surgeons see if any cancer remains after removing a sarcoma. About 50 adults with bone or soft tissue sarcoma will receive the dye during surgery, and the surgeon will check for glowing areas that might indicate lef…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
A quick test for septic arthritis in kids — could it save joints?
Diagnosis Recruiting nowThis study tests whether proteins in joint fluid, such as alpha-defensin, can quickly and accurately detect bacterial joint infections (septic arthritis) in children. Currently, doctors rely on cultures that take days, forcing tough decisions about emergency surgery. The trial co…
Phase: NA • Sponsor: Hospital for Special Surgery, New York • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
AI reads knee ultrasounds to predict injection success
Diagnosis Recruiting nowThis study is developing an artificial intelligence platform to analyze knee ultrasound images and predict outcomes after ultrasound-guided injections for degenerative knee disorders like osteoarthritis. Researchers will first train the AI to identify normal and abnormal knee str…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Could a simple online quiz replace the dentist's cavity risk exam?
Diagnosis Recruiting nowThis study tests whether a digital questionnaire can accurately assess a person's risk of developing cavities, compared to the standard clinical method (CAMBRA). About 384 Egyptian adults aged 18 to 65 will fill out the questionnaire and receive a clinical exam. The goal is to se…
Sponsor: October University for Modern Sciences and Arts • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
New Antibiotic-Coated nail aims to stop bone infections after severe leg breaks
Prevention Recruiting nowThis study tests whether coating a metal rod (intramedullary nail) with antibiotics (vancomycin and gentamicin) can prevent deep infections in people with severe open tibia fractures. About 484 adults with Gustilo Type II or III open tibia fractures will be randomly assigned to r…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Aug 19, 2026 08:00 UTC
-
Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
Prevention Recruiting nowThis study looks at whether a low dose of the antifungal drug liposomal amphotericin B can prevent serious fungal infections in adults with blood cancers or who have had stem cell transplants and have a prolonged low white blood cell count (neutropenia). The trial enrolls 30 pati…
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Could a simple dental cleaning prevent a deadly heart infection?
Prevention Recruiting nowThis trial investigates whether a professional dental cleaning and instruction on proper brushing and flossing can reduce the amount of bacteria that enter the bloodstream during tooth brushing. Such bacteria can sometimes lead to infective endocarditis, a serious infection of th…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
Weight loss and exercise may stop knee arthritis before it starts
Prevention Recruiting nowThis trial tests whether a 48-month program of dietary weight loss, exercise, and weight maintenance can prevent knee osteoarthritis in women aged 50 and older who have obesity and no or infrequent knee pain. Participants are randomly assigned to the diet-and-exercise program or …
Phase: NA • Sponsor: Wake Forest University • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
Could salt water be as good as steroids for thumb arthritis?
Symptom relief Recruiting nowThis study tests whether a simple saline (salt water) injection works as well as a steroid injection for thumb arthritis pain. Forty adults with thumb osteoarthritis will receive one injection, but neither they nor their doctor will know which one. The goal is to see if saline ca…
Phase: PHASE2 • Sponsor: Université du Québec à Trois-Rivières • Aim: Symptom relief
Last updated Aug 19, 2026 08:00 UTC
-
Heel pain breakthrough? study tests nerve combo treatment
Symptom relief Recruiting nowThis study looks at whether treating an extra nerve in the foot can improve pain relief for people with long-term heel pain. About 48 adults will receive a standard nerve treatment, with half also getting treatment on a second nerve. Researchers will measure pain and foot functio…
Sponsor: Diskapi Teaching and Research Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can a meditation practice curb Post-Surgery pain and opioid use?
Symptom relief Recruiting nowThis trial tests whether a brief course of savoring meditation—a practice that generates positive emotions—can reduce pain and improve reward system function in people undergoing knee replacement for osteoarthritis. Half of the 150 participants will receive this meditation traini…
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New injection could ease jaw pain better than standard treatment
Symptom relief Recruiting nowThis study compares a new injection of liquid phase concentrated growth factor (LPCGF) to standard arthrocentesis (joint washing) for people with painful jaw clicking and limited mouth opening due to a displaced disc. Thirty-two adults aged 18-45 with unilateral disc displacement…
Phase: NA • Sponsor: Horus University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can a laser beam ease pain after Root-End surgery?
Symptom relief Recruiting nowThis trial tests whether photobiomodulation (PBM), a type of low-level laser therapy, can reduce pain and improve healing after endodontic microsurgery—a procedure to treat infections at the tip of a tooth root. About 90 adults needing this surgery will receive either real PBM or…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New weekly shot could shed pounds and ease knee pain
Symptom relief Recruiting nowThis Phase 3 study tests a once-weekly injection called NNC0487-0111 in 400 adults who are overweight or obese and have knee osteoarthritis. The goal is to see if it helps with weight loss and reduces knee pain compared to a placebo. Participants receive either the active drug or…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Could your own fat ease shoulder arthritis pain?
Symptom relief Recruiting nowThis study compares injections of a patient's own processed fat tissue (MFAT) against standard steroid shots for shoulder osteoarthritis. Researchers will track pain, function, and quality of life in 48 adults aged 25-75. The goal is to see if the fat injection provides better or…
Phase: PHASE1 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Tailored exercise may ease symptoms of rare blood cancer
Symptom relief Recruiting nowThis study tests whether a 3-month personalized exercise program can improve quality of life, fitness, and symptoms in people with myeloproliferative neoplasms (MPN), a group of rare blood cancers. About 80 participants will be randomly assigned to either start the exercise progr…
Phase: NA • Sponsor: Hannover Medical School • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New knee pain drug enters human testing
Symptom relief Recruiting nowThis early-stage study tests a drug called CX-011 for moderate to severe knee osteoarthritis pain. About 72 adults aged 18-75 with knee osteoarthritis will receive the drug via injection into the knee joint. The main goals are to check safety and tolerability, and to see if it re…
Phase: PHASE1, PHASE2 • Sponsor: CarthroniX, Inc. • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
One and done: new study tests Single-Visit radiation for bone metastases
Symptom relief Recruiting nowThis study tests whether a single, quick radiation session can treat painful bone metastases without the usual planning visit. About 40 adults with cancer and one or two painful bone spots will get one dose of radiation in a single trip to the hospital. The goal is to see if this…
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Healing harmonies: music therapy aims to ease stem cell transplant recovery
Symptom relief Recruiting nowThis study tests an online music therapy program that combines mindfulness and music to help people recovering from stem cell transplants for blood cancers. Researchers want to see if it can improve quality of life, reduce pain, fatigue, anxiety, and depression, and possibly spee…
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Gum surgery showdown: which stitch heals best?
Symptom relief Recruiting nowThis study compares two types of stitches (NOVOSYN quick and MONOSYN quick) used in gum surgery to see if they heal equally well. About 84 adults having gum surgery will be randomly assigned one of the two stitches. The main goal is to check early healing signs like skin regrowth…
Phase: NA • Sponsor: Aesculap AG • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Robot knee surgery showdown: can skipping the scan still deliver?
Symptom relief Recruiting nowThis study compares two robot-assisted knee replacement methods for people with severe knee arthritis. One method uses a CT scan to plan the surgery (image-based), while the other uses a simpler approach without a scan (imageless). The goal is to see if the imageless method works…
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Blocking knee blood vessels may offer new pain relief for severe osteoarthritis
Symptom relief Recruiting nowThis trial tests whether genicular artery embolization (GAE), a procedure that blocks certain blood vessels in the knee, can reduce persistent pain in people with severe knee osteoarthritis who haven't found relief from conservative treatments and may not be candidates for surger…
Phase: NA • Sponsor: King Abdullah International Medical Research Center • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can education boost exercise compliance for chronic pain sufferers?
Symptom relief Recruiting nowThis trial tests whether adding a structured patient education program to standard physical therapy helps people with chronic low back pain, knee osteoarthritis, or shoulder pain stick to their prescribed home exercises. Participants will be randomly assigned to receive either st…
Phase: NA • Sponsor: Imam Abdulrahman Bin Faisal University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a digestive enzyme combo beat standard painkillers for root canal pain?
Symptom relief Recruiting nowThis trial tests three pain-relief approaches after a single-visit root canal in people with symptomatic irreversible pulpitis, a painful tooth condition. Participants receive either acetaminophen, an NSAID, or a combination of trypsin-chymotrypsin with acetaminophen for three da…
Phase: EARLY_PHASE1 • Sponsor: Dow University of Health Sciences • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could an antidepressant curb opioid use after knee surgery?
Symptom relief Recruiting nowThis study tests whether the antidepressant duloxetine can help reduce opioid painkiller use after knee replacement surgery. About 150 adults with knee osteoarthritis will receive either duloxetine or a placebo before and after surgery. The goal is to see if duloxetine lowers opi…
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Light-Activated nails could ease pain from pelvic cancer spread
Symptom relief Recruiting nowThis early-phase trial is testing whether a minimally invasive procedure using special light-activated nails can help stabilize the pelvis in people whose cancer has spread to the bone around the hip socket. Fifty adults with confirmed cancer and visible pelvic metastases will be…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Massage guns vs. manual therapy: which eases shoulder pain better?
Symptom relief Recruiting nowThis trial compares two hands-on therapies—percussion massage with a handheld device and instrument-assisted soft tissue mobilization—when added to standard physiotherapy for people with shoulder impingement syndrome. About 48 adults aged 40–60 with confirmed impingement will be …
Phase: NA • Sponsor: Emre DANSUK • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can cutting carbs curb knee pain? a diet trial puts it to the test
Symptom relief Recruiting nowThis study investigates whether a low-carbohydrate diet can reduce pain and improve quality of life in adults with knee osteoarthritis, compared to a standard USDA-recommended diet. Participants will follow a 6-week diet plan with all meals provided, and researchers will measure …
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Talking about the end: could guided conversations reduce futile cancer treatments?
Symptom relief Recruiting nowThis trial tests a program called ACT, which trains doctors and nurses to have compassionate, structured conversations with blood cancer patients and their families about end-of-life care. The goal is to help patients understand their prognosis and make informed decisions, potent…
Phase: NA • Sponsor: Christoffer Johansen • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New radiation technique may ease cancer bone pain better than standard therapy
Symptom relief Recruiting nowThis phase 3 trial tests whether a precise, high-dose radiation technique (SBRT) provides better pain relief than standard radiation for cancer patients with painful bone metastases not in the spine. About 230 adults with solid tumors and moderate to severe pain will be randomly …
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New injection aims to ease arthritis pain in joints
Symptom relief Recruiting nowThis early-stage study tests a new drug called F8IL10, given as an injection directly into the joint, for people with rheumatoid arthritis. The main goal is to find a safe dose and see if it helps reduce joint pain and swelling. About 42 adults with active arthritis in a knee, an…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
Symptom relief Recruiting nowThis study tests whether adding lymphatic pump osteopathic manipulative therapy (OMT) to standard care helps older adults recover faster from respiratory illnesses like bronchitis, sinusitis, or pneumonia. Participants aged 65 to 100 with a new respiratory diagnosis will receive …
Phase: NA • Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can sound waves outperform needles for Jumper's knee?
Symptom relief Recruiting nowThis trial compares two non-surgical treatments for jumper's knee, a common overuse injury causing knee pain. Half the participants will receive extracorporeal shockwave therapy, which uses sound waves to stimulate healing, while the other half will receive dry needling, which in…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Which knee exercise works best for anterior knee pain? new study aims to find out
Symptom relief Recruiting nowThis study compares three types of knee-strengthening exercises (isometric, isotonic, and eccentric) in 90 adults aged 18-40 with patellofemoral pain syndrome. Participants will do their assigned exercises three times a week for 8 weeks, alongside standard physiotherapy. Research…
Phase: NA • Sponsor: Firat University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Could a few needles ease your jaw pain?
Symptom relief Recruiting nowThis study tests whether adding dry needling to standard physical therapy helps people with jaw pain (TMJ dysfunction). One hundred adults will either get standard rehab alone or rehab plus dry needling. Researchers will measure pain, jaw movement, and quality of life to see if t…
Phase: NA • Sponsor: Palacky University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Freeze or zap? new trial tests Drug-Free pain relief for stubborn knee arthritis
Symptom relief Recruiting nowThis study compares two minimally invasive procedures—cryoneurolysis (freezing nerves) and radiofrequency (using electric pulses)—to relieve knee pain in adults with osteoarthritis who haven't responded to standard treatments like painkillers or physical therapy. Sixty participan…
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a liquid adhesive make clubfoot treatment stick better?
Symptom relief Recruiting nowThis study tests whether applying Mastisol, a liquid adhesive, during clubfoot casting helps babies with clubfeet get better faster and with fewer problems. Researchers will compare outcomes like how many weeks of casting are needed and how often complications like sores or swell…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Magic mushrooms tested for depression in veterans with spinal injuries
Symptom relief Recruiting nowThis study tests whether psilocybin (the active ingredient in magic mushrooms) is safe and tolerable for veterans with spinal cord injury who also have depression. Thirty participants will receive low, medium, or high doses and be monitored for side effects like pain, muscle spas…
Phase: PHASE1, PHASE2 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can an online course ease fatigue in autoimmune disease?
Symptom relief Recruiting nowThis study tests an online wellness course that teaches diet, exercise, stress reduction, and self-care to people with rheumatoid arthritis, lupus, Sjogren's syndrome, and similar conditions. Researchers want to see if the program reduces fatigue and improves quality of life. Abo…
Phase: NA • Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Smart bandage zaps chronic wounds to speed healing
Symptom relief Recruiting nowThis pilot study tests a new flexible bandage called exciflex that delivers mild electrical stimulation to chronic wounds that won't heal normally. The study includes 16 veterans with diabetes or spinal cord injury who have lower leg wounds. The bandage is designed to work for up…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Which nerve drug wins the battle against Post-Surgical knee pain?
Symptom relief Recruiting nowThis trial asks whether mirogabalin or pregabalin provides better pain relief after total knee replacement surgery. Adults aged 50-85 with knee osteoarthritis will take one of the two drugs for two weeks after surgery. Researchers will measure pain scores, morphine use, and knee …
Phase: NA • Sponsor: Thammasat University Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can light therapy unlock stiff fingers?
Symptom relief Recruiting nowThis trial tests whether adding low-level laser therapy to a standard splint can ease the pain and locking of trigger finger, a common hand condition. About 91 people with trigger finger will receive either real laser treatment or a sham (inactive) laser, three times a week for f…
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Could fixing sleep before knee surgery cut Long-Term pain?
Symptom relief Recruiting nowThis study tests whether improving sleep before total knee replacement surgery can reduce pain after the operation. Adults aged 60 and older with knee osteoarthritis and sleep difficulties will receive either cognitive-behavioral therapy for insomnia, bright light therapy, or a c…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can specialized exercise ease knee arthritis disability?
Symptom relief Recruiting nowThis trial tests whether eccentric strengthening exercises or low-load blood flow restriction training can improve muscle function, strength, and daily mobility in people with knee osteoarthritis. Participants aged 40 to 70 with mild to moderate knee arthritis will follow a four-…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Early rehab after spine surgery: could two weeks be better than six?
Symptom relief Recruiting nowThis study looks at whether starting physical therapy two weeks after cervical spine surgery helps adults with degenerative myelopathy recover walking, balance, and strength better than waiting six weeks. Twenty participants will be randomly assigned to start rehab at either two …
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Toothpaste showdown: new study pits three formulas against sensitive teeth
Symptom relief Recruiting nowThis Phase 3 trial compares three different toothpaste technologies for relieving tooth sensitivity (dentin hypersensitivity). About 132 adults with sensitive teeth will brush with one of three toothpastes: one with 8% arginine, one with 8% arginine plus zinc, or one with 5% calc…
Phase: PHASE3 • Sponsor: Colgate Palmolive • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
One-Shot gene therapy could ease knee arthritis pain for years
Symptom relief Recruiting nowThis Phase 2 trial tests a single injection of a gene therapy called PCRX-201 in 135 adults aged 45–80 with painful knee osteoarthritis. Participants receive one of two doses or a placebo, then are monitored for safety and pain relief over 5 years. The goal is to see if the injec…
Phase: PHASE2 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
Symptom relief Recruiting nowThis pilot study tests a care model called Patient Priorities Care (PPC) for older African Americans with heart disease plus other chronic conditions like diabetes or COPD. The approach shifts focus from treating each disease separately to aligning care with what matters most to …
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Can shock waves or electrotherapy ease Menopause-Linked tennis elbow?
Symptom relief Recruiting nowThis trial tests whether a combination of electrotherapy (low-level laser and interferential current) or shock wave therapy, alongside stretching and strengthening exercises, can reduce pain and improve grip strength in menopausal women with tennis elbow. The study includes 45 wo…
Phase: NA • Sponsor: October 6 University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
New daily pill could ease knee pain and help weight loss in obesity
Symptom relief Recruiting nowThis study tests a once-daily pill called orforglipron in 800 adults with obesity or overweight who also have painful knee osteoarthritis. The goal is to see if the drug reduces knee pain and improves physical function over about 74 weeks. Participants will be randomly assigned t…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Spine radiation study aims to cut fracture risk
Symptom relief Recruiting nowThis study tests whether giving spine radiation in one session or two sessions better prevents bone fractures in people with cancer that has spread to the spine. About 130 adults with spine tumors will receive either one or two focused radiation treatments. The goal is to find wh…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
New weekly shot aims to ease arthritic knee pain and shed pounds
Symptom relief Recruiting nowThis Phase 3 study tests a once-weekly injection called eloralintide in 900 adults with osteoarthritis of the knee who are also overweight or obese. The goal is to see if it reduces knee pain and helps with weight loss compared to a placebo. Participants will be in the study for …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Phone app aims to speed recovery after hip, knee, and spine surgery
Symptom relief Recruiting nowThis study tests whether a mobile app can help patients do simple in-bed exercises after orthopedic surgery for spine, hip, or knee problems. About 100 participants will use the app or receive usual care. Researchers will measure how well patients recover their ability to move an…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Could gentle manual therapy unlock relief for chronic jaw pain?
Symptom relief Recruiting nowThis trial tests whether a specific type of manual therapy, based on the Fascial Distortion Model, can reduce pain and improve function in people with temporomandibular disorders (TMD), which cause jaw, face, or neck pain. Participants are randomly assigned to receive either the …
Phase: NA • Sponsor: Karabuk University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Gum graft recovery: which palatal shield hurts least?
Symptom relief Recruiting nowThis study tests three different methods to protect the roof of the mouth after a gum graft. Fifty-six adults will rate their pain, swelling, and bleeding using a simple scale. The goal is to find which protection technique makes healing most comfortable.
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can simple exercises or TENS ease diabetic shoulder pain?
Symptom relief Recruiting nowThis trial compares two non-drug approaches—isometric strengthening exercises and transcutaneous electrical nerve stimulation (TENS)—to see which better relieves shoulder pain and improves movement in people with type 2 diabetes. Adults aged 40-65 with diabetes-related frozen sho…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Shock wave or splint? new study tests best treatment for trigger finger
Symptom relief Recruiting nowThis study compares two common treatments for trigger finger: shock wave therapy and a finger splint. Researchers will enroll 54 adults with early-stage trigger finger to see which approach better reduces pain and improves hand function. The goal is to find out if shock wave ther…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New rehab approach aims to get young athletes back in the game pain-free
Symptom relief Recruiting nowThis study tests a 12-week individualized rehabilitation program for youth athletes aged 10–17 with Osgood-Schlatter disease (knee pain) or Sever disease (heel pain). The program includes education, pain monitoring, and tailored exercises. Researchers want to see if it's feasible…
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New gel injection aims to soothe sore tendons
Symptom relief Recruiting nowThis study is testing a gel called OSTENIL TENDON to see if it safely reduces pain and improves movement in people with tendon problems. Researchers will enroll 84 adults with one of four types of tendinopathy. The main goal is to measure pain changes three months after treatment…
Sponsor: TRB Chemedica AG • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Could a mix of moves and mindset ease frozen shoulder?
Symptom relief Recruiting nowThis study tests whether a combination of special joint mobilizations, pain education, and core exercises can reduce pain and improve shoulder function in people with frozen shoulder. Thirty-six adults with the condition will be randomly assigned to either this new program or sta…
Phase: NA • Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Laser light may soothe growing pains in young athletes
Symptom relief Recruiting nowThis study tests whether low-level laser therapy (a painless light treatment) can reduce knee or heel pain in active kids aged 10–17 with Osgood-Schlatter or Sever disease. About 30 young athletes will receive either real laser or a sham (fake) treatment over two weeks. Researche…
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a VR headset replace the Dentist's drill of fear?
Symptom relief Recruiting nowThis study tests whether wearing a virtual reality headset during dental procedures can reduce pain and anxiety compared to standard care. Adults needing similar fillings on both sides of their mouth will receive one side with VR distraction and the other without, allowing a dire…
Phase: NA • Sponsor: Qassim University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Can Mountain-Air breathing boost leg strength after spinal injury?
Symptom relief Recruiting nowThis trial tests whether brief, controlled episodes of breathing lowered oxygen — similar to being on a tall mountain — can improve leg strength and reaction time in people with incomplete spinal cord injury. Participants will receive different doses of this low-oxygen therapy or…
Phase: NA • Sponsor: Milap Sandhu • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Targeted needles and magnetic pulses aim to ease Nerve-Related neck pain
Symptom relief Recruiting nowThis trial tests whether high-frequency electroacupuncture at specific neck points, combined with pulsed electromagnetic field therapy, can reduce pain and improve neck function better than standard electroacupuncture plus the same magnetic therapy. The study includes 104 adults …
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
3D-Printed dental guide aims to boost precision in Root-End surgery
Symptom relief Recruiting nowThis trial tests whether a custom 3D-printed surgical guide can improve the accuracy of apicoectomy—a procedure to remove the tip of a tooth root after a failed root canal. Participants will have the guided surgery and then report pain and swelling at 1, 3, and 7 days. At 6 month…
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a simple pressure-sensing device beat foam rolling for knee arthritis pain?
Symptom relief Recruiting nowThis trial tests whether pressure biofeedback training—using a device that shows how hard you press—can reduce pain and improve muscle function better than bolster foam rolling in people with knee osteoarthritis. Forty-eight participants with moderate knee arthritis will do one o…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Zapping nerves before knee surgery may cut pain — trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether a nerve-blocking procedure called genicular nerve radiofrequency ablation, done two to six weeks before total knee replacement, can reduce postoperative pain and improve function. The study includes adults aged 18 to 60 who are scheduled for knee replacem…
Phase: NA • Sponsor: Anesthesiology department Iris South Hospitals • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Could a walk a day keep brain fog away after a stem cell transplant?
Symptom relief Recruiting nowThis study tests whether a tailored physical activity program can help older adults maintain thinking and memory after a stem cell transplant for blood cancers. Participants aged 60 and older will follow a progressive, light-to-moderate exercise plan with support from therapists …
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a neck glide unlock a frozen shoulder?
Symptom relief Recruiting nowThis trial compares two hands-on treatments for frozen shoulder (adhesive capsulitis): spinal mobilization with arm movement (SMWAM) and Kaltenborn mobilization. Both aim to reduce pain, improve range of motion, and ease disability. The study includes 50 adults aged 35–50 with mo…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Energy healing put to the test: can reiki reduce Post-Surgery pain?
Symptom relief Recruiting nowThis trial investigates whether Reiki, a gentle hands-on energy therapy, can help reduce pain and improve recovery in people undergoing lumbar spine surgery. Sixty participants will be randomly assigned to receive either two sessions of real Reiki or a sham (placebo) treatment al…
Phase: NA • Sponsor: Clinique Bizet • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can a steroid cocktail beat the standard nerve block for knee replacement pain?
Symptom relief Recruiting nowThis trial compares two types of nerve blocks for pain control after bilateral total knee replacement. One combines a standard numbing medication with two steroids, the other uses a long-acting liposomal bupivacaine. Researchers want to see if the steroid-enhanced block provides …
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Steroid cocktail may offer better pain control after knee replacement
Symptom relief Recruiting nowThis phase 2 trial tests whether a nerve block containing bupivacaine plus two steroids (dexamethasone and methylprednisolone) can provide better pain relief after total knee replacement than the standard combination of bupivacaine and liposomal bupivacaine (Exparel). About 250 a…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Nerve flossing for athletes: a simple technique that could keep hamstrings strong?
Symptom relief Recruiting nowThis trial tests whether three types of nerve-gliding exercises — called neurodynamics — can improve hamstring strength and endurance in athletes aged 18 to 30 who play organized sports or train regularly. The exercises aim to improve nerve mobility and reduce pain, and the study…
Phase: NA • Sponsor: High Point University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Can the right anesthesia get knee replacement patients moving faster?
Symptom relief Recruiting nowThis trial compares three regional anesthesia techniques after total knee replacement to see which one helps patients regain knee movement best. Adults scheduled for knee replacement will be randomly assigned to one of three groups: spinal anesthesia with an epidural, a nerve blo…
Phase: NA • Sponsor: Konya City Hospital • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could a pinch of radiation ease arthritis pain?
Symptom relief Recruiting nowThis study investigates whether low-dose radiation therapy (LDRT) can reduce pain and improve function in people with osteoarthritis of the hips, knees, hands, shoulders, ankles, or elbows. Participants who have not responded to standard treatments will receive one or two courses…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Brain zaps and ancient exercise join forces to fight knee pain
Symptom relief Recruiting nowThis study investigates whether combining a gentle mind-body exercise called Baduanjin with a non-invasive brain stimulation technique (tDCS) can help relieve pain and improve brain function in people with knee osteoarthritis. Researchers will use brain scans to see how these tre…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Ear nerve zaps may unfreeze shoulders: new trial tests pain relief without drugs
Symptom relief Recruiting nowThis study tests whether adding a gentle electrical stimulation to the ear (transcutaneous auricular vagus nerve stimulation, or taVNS) to standard physiotherapy can reduce pain, improve shoulder movement, and boost quality of life in adults with frozen shoulder (adhesive capsuli…
Phase: NA • Sponsor: Muhsin Doran • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Could a gentler solution replace acid for brighter teeth?
Symptom relief Recruiting nowThis trial compares a new cleaning solution called Antivet against two acids (phosphoric and hydrochloric) for removing mild to moderate stains from teeth using a microabrasion technique. Participants are people aged 16 to 50 with stained front teeth. The goal is to see if Antive…
Phase: PHASE1 • Sponsor: Misr University for Science and Technology • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could a tiny nerve zap ease stubborn knee arthritis pain?
Symptom relief Recruiting nowThis study looks at whether adding a targeted nerve treatment to a standard procedure can better relieve chronic knee pain from osteoarthritis. Researchers are comparing standard radiofrequency treatment alone versus standard treatment plus pulsed radiofrequency on specific senso…
Sponsor: Diskapi Teaching and Research Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Can simple leg dangles or electrical pulses ease knee arthritis pain?
Symptom relief Recruiting nowThis study tests two non-drug treatments for knee osteoarthritis: weighted dangling exercises (gravity-assisted leg swings with ankle weights) and neuromuscular electrical stimulation targeting a key thigh muscle. Researchers will compare how well each approach reduces pain and i…
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Massive new study to track spine tumor patients after surgery and radiation
Knowledge-focused Recruiting nowThis study is following 3,000 adults with spine tumors (either primary or that have spread from elsewhere) who undergo surgery to relieve pressure on the spine, followed by radiation. Researchers are tracking how long patients live, whether the tumor stays under control, and how …
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
New study to see which back procedure keeps seniors out of surgery
Knowledge-focused Recruiting nowThis study will follow 8,000 Medicare patients with lumbar spinal stenosis who receive either the MILD procedure or interspinous process decompression. Researchers will track complications and whether patients need additional surgery within two years. The goal is to see which app…
Sponsor: Stryker Instruments • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Scientists launch major study to unravel rare bone disease
Knowledge-focused Recruiting nowThis study follows up to 500 people with polyostotic fibrous dysplasia or McCune-Albright syndrome to learn how these conditions change over time. Researchers will collect medical data and tissue samples to better understand the disease. The goal is to improve future diagnosis an…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Watching and learning: how cancer screenings affect people with fanconi anemia
Knowledge-focused Recruiting nowThis study looks at anxiety related to cancer screenings in adults with Fanconi anemia, a rare condition that raises cancer risk. Researchers will observe 20 participants during their regular screening visits, noting body language, worries, and the clinic environment. No treatmen…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Massive study aims to uncover cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Simple blood test may predict how badly back pain affects your life
Knowledge-focused Recruiting nowThis study will check if a protein called periostin in the blood is related to how much back pain limits daily activities and quality of life. Researchers will measure periostin in 38 adults with lumbar disc problems and compare it to their scores on disability and health questio…
Sponsor: Keimyung University Dongsan Medical Center • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
AI decodes the mystery of persistent pain in rheumatoid arthritis
Knowledge-focused Recruiting nowThis observational study aims to understand why some people with rheumatoid arthritis (RA) continue to experience chronic pain even when their inflammation is well-controlled. Researchers will compare two groups of RA patients—those with active disease and those in remission with…
Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Common painkillers may alter key protein in back pain patients
Knowledge-focused Recruiting nowThis study looks at whether taking NSAIDs (like ibuprofen) changes the level of a protein called periostin in the blood of people with degenerative disc disease. Researchers will compare three groups: patients using NSAIDs, patients not using NSAIDs, and healthy people without ba…
Sponsor: Keimyung University Dongsan Medical Center • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Robot-Assisted joint surgery under the microscope: will it help implants last longer?
Knowledge-focused Recruiting nowThis study will follow about 950 people who receive hip or knee replacements using Stryker implants, some with the Mako robotic-arm system and some without. Researchers will track how long the implants last and how well patients feel and function over five years. The goal is to g…
Sponsor: Stryker Orthopaedics • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Which PRP machine works best for knee arthritis? small study aims to find out
Knowledge-focused Recruiting nowThis study will compare two FDA-approved machines that make platelet-rich plasma (PRP) for people with knee osteoarthritis. PRP is made from a person's own blood and is injected into the knee to help with pain and stiffness. The researchers will check if the two machines produce …
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Scientists track rare gene variant to unlock blood disorder mysteries
Knowledge-focused Recruiting nowThis study follows people of all ages who have or may have a RUNX1 gene variant, which can cause bleeding problems and increase the risk of blood cancers. Researchers will collect medical history, blood samples, and bone marrow over many years to understand how the condition deve…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
NCI opens screening study for experimental cell therapies in multiple cancers
Knowledge-focused Recruiting nowThis study screens adults with certain cancers (like melanoma, lung, or colorectal cancer) to see if they qualify for experimental treatments being tested by the NCI Surgery Branch. These treatments involve taking a patient's own immune cells, growing them in a lab, and giving th…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 08:00 UTC
-
Could a recovery checklist speed healing after brain tumor surgery?
Knowledge-focused Recruiting nowThis study looks at whether a structured recovery program called Enhanced Recovery After Surgery (ERAS) can improve outcomes for people undergoing endoscopic surgery to remove pituitary tumors. Researchers will track complications, pain, nausea, hospital stay length, and readmiss…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Massive study aims to unlock mysteries of rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows up to 4,000 people with vasculitis (a group of diseases that cause blood vessel inflammation) and healthy volunteers over many years. Researchers collect blood, urine, imaging, and genetic samples to learn how the disease develops and changes. The goal is to fi…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
500 patients to help unlock secrets of knee recovery
Knowledge-focused Recruiting nowThis study will follow 500 people with knee injuries or knee osteoarthritis who receive standard care at a hospital in China. Researchers will collect medical history, imaging, and function tests at the start and then again at 6, 12, and 24 months. The goal is to better understan…
Sponsor: Ningbo No.2 Hospital • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New screening trial aims to speed up matching of cancer patients to the right treatments
Knowledge-focused Recruiting nowThis study tests a new way to screen patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) by analyzing their bone marrow and blood for specific biomarkers. The goal is to quickly match patients with a treatment trial that targets their cancer's unique mark…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New imaging study aims to unlock secrets of human movement
Knowledge-focused Recruiting nowThis study uses MRI and ultrasound to watch how muscles, tendons, and bones work together when you move. Researchers hope to learn what normal and injured movement looks like, which could lead to better ways to diagnose and treat problems like knee pain. Healthy volunteers and pe…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Your wisdom teeth could help science: study seeks tissue samples
Knowledge-focused Recruiting nowThis study collects wisdom teeth and surrounding tissue that are normally thrown away after oral surgery. Researchers will use these samples to learn more about oral health and disease. Up to 3,000 people aged 16 to 50 who need their wisdom teeth removed can join. The study also …
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New study aims to unlock secrets of rare cholesterol diseases
Knowledge-focused Recruiting nowThis natural history study is observing up to 250 people with Smith-Lemli-Opitz syndrome and related cholesterol disorders, as well as their relatives. Researchers will track symptoms, development, and lab results over several years to find better ways to measure disease progress…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Scientists hunt for genetic clues behind childhood pituitary tumors
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of pituitary and hypothalamic tumors in children. Researchers will collect blood and tumor samples from up to 2,000 participants to analyze DNA and look for inherited patterns. The study also trains doctors and tests new MRI technique…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Massive spine device registry launches to see how medtronic tools perform in real surgeries
Knowledge-focused Recruiting nowThis study will follow 1,000 people receiving Medtronic spinal or cranial devices during routine surgery. Researchers will track outcomes like fusion success, pain relief, and device safety for up to two years. The goal is to gather real-world data on how these already-approved p…
Phase: NA • Sponsor: Medtronic Spinal and Biologics • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Can your genes predict eye damage from a common arthritis drug?
Knowledge-focused Recruiting nowThis study looks at whether certain genes make some people more likely to develop eye damage from the drug Plaquenil, which is used for autoimmune diseases like lupus and rheumatoid arthritis. Researchers will compare people who have had eye damage from Plaquenil with those who h…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Ultrasound measurements may predict who benefits from knee pain block
Knowledge-focused Recruiting nowThis study looks at whether ultrasound measurements of thigh muscle and fat can predict how well patients with knee osteoarthritis respond to a genicular nerve block. Researchers will measure muscle thickness and fat under the skin before the procedure and check pain levels one m…
Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Can men with spinal cord injury father children? a new study explores fertility options
Knowledge-focused Recruiting nowThis study aims to understand and improve fertility in men with spinal cord injury. Researchers will collect and analyze semen samples from participants to assess sperm count, motility, and other factors, and correlate these with patient characteristics. The goal is to help men w…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Scientists track rare bone cancer to unlock future treatments
Knowledge-focused Recruiting nowThis study follows 300 children and adults with chordoma, a rare bone cancer of the skull base or spine. Researchers will track how the disease progresses over time using imaging, physical exams, and surveys. The goal is to better understand chordoma's behavior to design more eff…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Scientists investigate rare overgrowth disorder proteus syndrome
Knowledge-focused Recruiting nowThis study aims to understand the genetic and biological causes of Proteus syndrome, a rare condition causing abnormal growth of bones, skin, and other tissues. Researchers will follow up to 1,500 participants over time, using medical exams, imaging, and blood tests to track how …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Why does jaw pain persist? scientists probe the Body's pain brakes
Knowledge-focused Recruiting nowThis study investigates whether people with chronic temporomandibular disorders (TMD) have a less effective natural pain inhibition system compared to healthy individuals. Researchers will apply carefully controlled heat stimuli to the face and other body parts to measure how wel…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can discarded bone reveal the secrets to stronger bones?
Knowledge-focused Recruiting nowThis study aims to understand why bones weaken with age, leading to conditions like osteoporosis and osteoarthritis. Researchers will collect bone waste and blood samples from 2,000 people undergoing orthopedic surgery, including those with and without bone disease. By analyzing …
Sponsor: Relation Therapeutics • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Massive study to track what happens when AML comes back
Knowledge-focused Recruiting nowThis observational study will follow 4,000 people whose acute myeloid leukemia has returned or not responded to treatment. Researchers will collect data from routine care to understand survival rates and treatment patterns over up to 4 years. No new drugs are being tested; the go…
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Tiny coil placed inside nose could help surgeons spot hidden brain tumors
Knowledge-focused Recruiting nowThis study tests a small MRI coil placed inside the sphenoid sinus during pituitary tumor surgery. The goal is to see if it can provide clearer images of tiny tumors that standard MRI often misses. About 70 adults with pituitary tumors will take part. The coil is inserted through…
Phase: NA • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Cured of cushing as a kid? scientists want to track your health for years
Knowledge-focused Recruiting nowThis study looks at the long-term health of people who were cured of Cushing disease before age 21. Researchers want to understand how past high cortisol levels affect the body and mind years later. Participants will complete surveys and have check-ups every 5 years. The goal is …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Shoulder replacement study peers inside muscles years later
Knowledge-focused Recruiting nowThis study looks at how the rotator cuff muscles are doing one and two years after total shoulder replacement surgery. Researchers will use EMG and CT scans to check for nerve damage or tears in the muscles. About 30 adults who had shoulder replacement for osteoarthritis will tak…
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Massive study aims to unlock genetic secrets of childhood hormone disorders
Knowledge-focused Recruiting nowThis study enrolls up to 15,000 children with known or suspected endocrine or metabolic disorders, along with their family members. Researchers will collect medical records, blood, saliva, and other samples to identify genetic changes linked to these conditions. The goal is to be…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Simple blood test could predict transplant complications
Knowledge-focused Recruiting nowThis study looks at a new method to measure special immune cells called iNKT cells in the blood of patients who have had a stem cell transplant. These cells may help predict serious complications like graft-versus-host disease (GvHD) and relapse. Researchers will test 75 adults w…
Sponsor: University Hospital Pilsen • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Braces and bacteria: can we predict cavities during orthodontic treatment?
Knowledge-focused Recruiting nowThis study follows 150 children and teens aged 8-18 who are getting braces to see how the treatment changes the bacteria in their mouths and the proteins in their saliva. Researchers will collect plaque and saliva samples before and during treatment to track these changes. The go…
Sponsor: Xi'an Jiaotong University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Massive lung disease registry aims to unlock secrets of progressive fibrosis
Knowledge-focused Recruiting nowThis registry is following 3,000 adults with idiopathic pulmonary fibrosis (IPF) or other chronic fibrosing interstitial lung diseases (ILDs) to understand how these conditions progress over time. Researchers collect information on symptoms, treatments, quality of life, and store…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can DNA glitches predict prostate cancer treatment success?
Knowledge-focused Recruiting nowThis study looks at men with advanced prostate cancer that has spread to the bones. Researchers want to see if certain DNA repair problems in the cancer cells make the drug radium-223 work better or worse. The goal is to help doctors choose the best treatment for each patient in …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New study screens for hidden genetic marker in mysterious mast cell disorders
Knowledge-focused Recruiting nowThis study aims to find how common the KIT D816V mutation is in people with suspected clonal mast cell disease. Researchers will collect blood samples from 450 participants and test them using two sensitive methods. The results may improve understanding and diagnosis of these rar…
Sponsor: Blueprint Medicines Corporation • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could a simple blood test flag heart risk in rheumatoid arthritis?
Knowledge-focused Recruiting nowThis study looks at whether certain markers of oxidative stress in the blood are linked to early signs of heart disease in people with rheumatoid arthritis. Researchers will measure these markers and check for thickening or stiffness in the carotid arteries. The goal is to better…
Sponsor: University of La Laguna • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Ultrasound may predict which patients get poor pain relief from a common knee block
Knowledge-focused Recruiting nowAfter knee replacement, a nerve block called the adductor canal block is often used to control pain while preserving leg strength. But it does not work equally well for everyone. This study will examine whether ultrasound measurements—such as tissue depth and nerve visibility—can…
Sponsor: Konya City Hospital • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Coin flip chemo: study tests if patients will let a computer choose their treatment strength
Knowledge-focused Recruiting nowThis study looks at whether adults with acute myeloid leukemia (AML) who are not healthy enough for strong chemotherapy are willing to let a computer randomly assign them to either lower- or higher-intensity treatment. The goal is to see if this approach is acceptable to patients…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
A simple blood test may reveal hidden infertility risk in young cancer survivors
Knowledge-focused Recruiting nowThis study investigates whether a blood marker called anti-Müllerian hormone (AMH) can predict future infertility in children and adolescents who have undergone cancer treatment. Many young patients recover normal menstrual cycles or puberty after chemotherapy, but their ovarian …
Sponsor: Erasme University Hospital • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could difficulty naming emotions worsen chronic tailbone pain?
Knowledge-focused Recruiting nowThis study investigates whether people with chronic tailbone pain (lasting 3 months or more) also have alexithymia — a condition where it's hard to identify and describe emotions. Researchers will use questionnaires to measure alexithymia, pain intensity, mood, childhood trauma, …
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Saliva test may catch implant gum disease early
Knowledge-focused Recruiting nowThis study looks at whether certain substances in spit and fluid around dental implants can help detect a gum disease called peri-implantitis early. Researchers will compare 80 people with healthy gums, regular gum disease, or implant-related gum disease. The goal is to find bett…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can pregnancy and neurological disease coexist safely? a new registry seeks answers
Knowledge-focused Recruiting nowThis study is a pregnancy registry that gathers information from women with chronic neurological conditions like multiple sclerosis, NMOSD, and myasthenia gravis who are planning pregnancy, currently pregnant, or within one year postpartum. Participants can contribute blood, brea…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New study checks if cancer drug olutasidenib changes how other medicines work
Knowledge-focused Recruiting nowThis study looks at how the cancer drug olutasidenib affects the way the body processes other medications. Researchers will give 16 adults with IDH1-mutated cancers a mix of test drugs before and during olutasidenib treatment to measure changes in drug levels. The goal is to ensu…
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
AI platform aims to unlock Real-World cancer data on a massive scale
Knowledge-focused Recruiting nowThis study enrolls people diagnosed with cancer to build a large registry using Olivia, an AI-powered health platform. The platform will collect and combine electronic health records and patient-reported outcomes from over 1,000 healthcare systems. The goal is to create a compreh…
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Dental implant dilemma: to keep or remove when jaw bone dies?
Knowledge-focused Recruiting nowThis study looks at patients who develop a condition called MRONJ (bone death in the jaw) after taking osteoporosis medications. When this happens around a dental implant, doctors disagree on whether to remove the implant or try to save it. The study will compare healing and bone…
Phase: NA • Sponsor: Kyunghee University Dental Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
NIH launches Long-Term study to track stem cell transplant survivors
Knowledge-focused Recruiting nowThis study provides ongoing check-ups for people who received a donor stem cell transplant at the NIH at least three years ago. Researchers will monitor for late side effects, disease return, and overall health. Participants will have yearly visits that may include blood tests, b…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
AI and a pulse oximeter may predict dangerous blood pressure swings in spinal cord injury
Knowledge-focused Recruiting nowThis study explores whether a measure called perfusion index (PI), taken from a pulse oximeter on the ear, finger, or toe, can reliably predict changes in blood pressure in people with spinal cord injury (SCI) during a cool temperature challenge. Participants with SCI and healthy…
Phase: NA • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Blood test breakthrough? new study aims to spot rare cancers earlier
Knowledge-focused Recruiting nowThis study looks at a type of immune cell called monocytes in people with certain blood cancers (polycythemia vera, essential thrombocythemia, and myelofibrosis). Researchers will analyze blood samples from 70 newly diagnosed patients to find unique patterns in these cells. The g…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Scientists launch major study to unravel mysterious metabolism disorders
Knowledge-focused Recruiting nowThis study aims to learn more about rare disorders that affect how the body processes chemicals called pyrimidines and purines. These disorders can cause problems in the brain, blood, kidneys, and immune system, ranging from mild to life-threatening. Researchers will compare test…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New tool aims to ease tough surgery decisions for kids with scoliosis
Knowledge-focused Recruiting nowThis study is testing a new decision support tool for parents and doctors of children with neuromuscular scoliosis who are considering surgery. About 110 parent-child pairs will either use the tool or receive usual care. Researchers will measure how the tool affects decision qual…
Phase: NA • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Talking gene therapy: new study seeks family insights
Knowledge-focused Recruiting nowThis study interviews patients and families who have experience with gene therapy for rare pediatric diseases, including sickle cell disease. Researchers want to understand their beliefs, attitudes, and what information they need. The goal is to create an online platform with edu…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could a symptom registry unmask hidden migraine variants?
Knowledge-focused Recruiting nowThis study is building a large online registry of US adults who experience sinus, ear, dizziness, and headache symptoms, with or without a migraine diagnosis. Participants answer questions about their symptoms, how these affect daily life, and which treatments they have tried. Th…
Sponsor: Association of Migraine Disorders • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can a patient registry unlock the secrets of a rare bone disorder?
Knowledge-focused Recruiting nowThis study creates a registry to collect medical information from people with rhizomelic chondrodysplasia punctata (RCDP) and closely related conditions. The goal is to better understand the natural history of these rare disorders and identify factors that may predict health outc…
Sponsor: Nemours Children's Clinic • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could a lifesaving leukemia drug harm Men's sexual health?
Knowledge-focused Recruiting nowThis study looks at whether tyrosine kinase inhibitors (TKIs), the standard treatment for chronic myeloid leukemia (CML), might be linked to erectile dysfunction (ED) in men. Researchers will track 350 male patients who started TKI therapy, using questionnaires and medical record…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Swimming pools may ease knee replacement wait: new study tests community program
Knowledge-focused Recruiting nowThis study looks at whether it's possible to run a larger trial of a community-based program called Good Boost+ for adults waiting for knee replacement surgery. The program includes weekly group water exercises and land-based exercises, plus peer support. Researchers will measure…
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
TMJ surgery: do the benefits last a decade?
Knowledge-focused Recruiting nowThis study follows 91 people who had jaw joint surgery (arthroscopy or disc removal) about 10 years ago. Researchers want to see if the improvements seen at 6 months still hold up over the long term, and how the joint changes on X-rays over time. The goal is to understand how sta…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
20-Year study to track rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows people with acquired or inherited bone marrow failure for up to 20 years to learn how the diseases and treatments affect the body over time. Participants, aged 2 and older, will have regular check-ups and tests every 1 to 3 years. The goal is to better understa…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scientists track rare brain diseases to unlock clues for future treatments
Knowledge-focused Recruiting nowThis study follows people with rare genetic disorders that cause harmful substances to build up in the body, leading to brain damage. Researchers will monitor up to 200 participants over time using exams, surveys, and lab tests. The goal is to better understand how these diseases…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scoliosis Surgery's Long-Term impact under the microscope
Knowledge-focused Recruiting nowThis study looks at adults aged 25-40 who had surgery for scoliosis as teenagers, comparing them to people with scoliosis who didn't have surgery and to healthy individuals. Researchers want to understand how the surgery affects daily life, pain, breathing, and quality of life ma…
Sponsor: Józef Piłsudski University of Physical Education • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Scientists dig into mouth bacteria to unlock immune secrets
Knowledge-focused Recruiting nowThis study looks at how genetic immune system problems might lead to gum disease and other mouth issues. Researchers will collect samples like saliva, plaque, and blood from 700 people, including those with immune defects, healthy adults with gum disease, and healthy adults witho…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Smartwatches could predict complications in bone cancer patients
Knowledge-focused Recruiting nowThis study is testing whether a smartwatch can track changes in walking and daily activities in people with bone cancer (osteosarcoma or metastatic bone disease). The goal is to see if the watch can help doctors spot problems early and personalize care. About 60 participants will…
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Blood test may personalize leukemia drug dosing
Knowledge-focused Recruiting nowThis study looks at whether measuring the amount of venetoclax in the blood can help doctors give the right dose to people with newly diagnosed acute myeloid leukemia (AML). Currently, everyone gets the same dose, but drug levels vary a lot between patients. The goal is to find a…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can ultrasound reveal how knee ligaments change with osteoarthritis?
Knowledge-focused Recruiting nowThis study uses a special ultrasound technique called shear wave elastography to measure the stiffness of knee ligaments in healthy adults and in people with knee osteoarthritis. The goal is to establish normal stiffness values across different ethnic groups and to see how ligame…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Beyond the curve: unpacking the hidden drivers of Well-Being in spinal deformity
Knowledge-focused Recruiting nowThis study looks at adults with spinal deformity to understand which factors—like pain, daily functioning, mental health, and frailty—most influence quality of life. It follows 320 people receiving either conservative care, first-time corrective surgery, or a reoperation, using q…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Scientists hunt for clues to cancer drug resistance in tissue samples
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 1,500 people with prostate or bladder cancer that has come back or spread. Researchers will analyze the samples to find genetic changes and other markers that may explain why some cancers stop responding to treatment. The goal is …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
2000 volunteers help create a gold standard for cancer blood tests
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people—some with cancer and some without—to create a blinded reference set. Researchers will use these samples to evaluate how well new blood tests can detect many types of cancer early. The goal is to improve the accuracy of…
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Massive blood cancer registry aims to unlock secrets of adult ALL
Knowledge-focused Recruiting nowThis study is a large registry that will collect medical information and biological samples from up to 10,000 adults with acute lymphoblastic leukemia (ALL) and related blood cancers. The goal is to track how patients are diagnosed, treated, and how they fare over time. By gather…
Sponsor: Goethe University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
A Child's saliva may hold the secret to cavity risk
Knowledge-focused Recruiting nowThis study looks at whether the proteins in the saliva of 3-year-old children can help predict their risk of developing early childhood caries (cavities). Researchers will compare saliva samples and dental exams from children in two different communities in Stockholm, Sweden, to …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Rare disease study seeks clues for future treatments
Knowledge-focused Recruiting nowThis study tracks the natural course of fucosidosis, a rare genetic disorder, in up to 57 people. It collects medical history and ongoing health data without giving any experimental treatment. The goal is to better understand the disease and help design future therapies.
Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Could a tight chest muscle be tearing your shoulder?
Knowledge-focused Recruiting nowThis study investigates whether tightness in the pectoralis minor, a small chest muscle, is linked to partial rotator cuff tears in the shoulder. Researchers will compare 45 patients with tears to 45 without, matching them by age, sex, body size, and dominant side. Using simple m…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
NIH launches major study to uncover why rheumatic diseases hit minorities harder
Knowledge-focused Recruiting nowThis study aims to learn more about the causes of rheumatic diseases—conditions that cause joint pain, stiffness, and swelling—and why they often affect minority groups more severely. Researchers will observe up to 7,500 adults with known or suspected rheumatic disease, providing…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New study measures radioactive drug safety in vulnerable patients
Knowledge-focused Recruiting nowThis study looks at how much of the radioactive drug Pluvicto reaches tumors and organs in patients whose kidneys or bone marrow are not working well. About 25 people will be enrolled to check for side effects and safety. The goal is to better understand dosing in these patients,…
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
NIH launches study to uncover genetic roots of Hormone-Driven high blood pressure in black communities
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of primary aldosteronism, a condition where adrenal tumors cause high blood pressure, in Black individuals. Researchers will enroll 1150 participants, including those with difficult-to-control blood pressure or known primary aldosteronis…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Scientists track spondyloarthritis in families to uncover clues to severe disease
Knowledge-focused Recruiting nowThis study follows up to 2,000 people with spondyloarthritis (a group of inflammatory joint and spine conditions) and their healthy relatives. Researchers aim to identify symptoms, genetic factors, and medical tests that predict who will develop more severe forms of the disease. …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Scientists study mast cells to unlock mastocytosis mysteries
Knowledge-focused Recruiting nowThis study collects bone marrow and blood samples from up to 600 people with mastocytosis, a condition where too many mast cells cause symptoms like itching and bone pain. Researchers will study what makes these cells grow and survive. The goal is to learn more about the disease,…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Which scan makes implant dentures fit best?
Knowledge-focused Recruiting nowThis study tests three different ways of taking digital impressions for lower jaw implant-supported dentures in people with no natural teeth. Each participant gets scanned with all three methods to see which one gives the most accurate implant positions and best fit. The goal is …
Phase: NA • Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
MRI as a window into bone marrow disease: a new biomarker test?
Knowledge-focused Recruiting nowThis study explores whether MRI scans can serve as biomarkers for myelofibrosis, a bone marrow disorder. Researchers will measure water diffusion and fat content in the bone marrow using MRI before, during, and after treatment. The goal is to see if these imaging parameters can d…
Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can the chemical signature of gum disease be detected?
Knowledge-focused Recruiting nowThis study looks at whether gum disease (periodontitis) changes the chemical makeup of the fluid that seeps from the gums. Researchers will compare samples from 30 adults with periodontitis and 30 healthy adults, all aged 18 to 70. During a single dental visit, participants will …
Sponsor: University of Catania • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can spinal stimulation rewire the injured nervous system?
Knowledge-focused Recruiting nowThis study investigates how epidural spinal cord stimulation (EES) influences communication between the brain, spinal cord, and muscles in people with spinal cord injury. Researchers will record electrical signals from the spine, brain, and muscles during temporary stimulation to…
Sponsor: Buddhist Tzu Chi General Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Retainer type may shape gum bacteria in ways that matter for oral health
Knowledge-focused Recruiting nowThis study looks at how fixed versus removable orthodontic retainers influence the types of bacteria living in the gum pockets and overall gum health. Ten adults who have finished braces will be split into two groups: one gets a fixed retainer bonded to the back of the teeth, the…
Phase: NA • Sponsor: Universidad de Murcia • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Tracking the emotional toll of a cancer diagnosis: when does anxiety peak?
Knowledge-focused Recruiting nowThis study follows adults with a suspected bone or soft tissue tumor to see how their stress and anxiety levels change at three critical moments: before biopsy, after learning the diagnosis, and when treatment begins. Participants fill out standard questionnaires about anxiety, d…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Chew your way to a new jawline? science puts hard gum to the test
Knowledge-focused Recruiting nowThis pilot study investigates whether regularly chewing a hard gum for four weeks can produce measurable changes in facial shape. Twenty healthy adults aged 20 to 40 will chew a standardized hard gum every other day, and researchers will use 3D facial imaging to track any shifts …
Phase: NA • Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can new criteria better spot a spine disease that mimics back pain?
Knowledge-focused Recruiting nowThis study aims to validate the 2025 ASAS-SPARTAN classification criteria for axial spondyloarthritis (axSpA) in Chinese patients with chronic back pain. AxSpA is a chronic inflammatory spine disease often misdiagnosed. Researchers will compare the new criteria against standard c…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can a smartphone replace a dental scanner for implant impressions?
Knowledge-focused Recruiting nowThis trial tests whether a smartphone-based photogrammetry system (T-Marker) can match or beat a specialized intraoral scanner with splinting bodies (IoConnect) for recording implant positions in people with full-arch dental implants. Each participant will be scanned with both me…
Phase: NA • Sponsor: Menoufia University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a simple scan reveal why muscles tire in phosphate diabetes?
Knowledge-focused Recruiting nowThis study uses a special MRI technique to measure energy molecules (ATP and phosphate) in the leg muscles of people with phosphate diabetes, a condition that causes bone pain and muscle fatigue. By comparing measurements at rest and during exercise, researchers hope to uncover t…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can mapping rare genetic variants unlock better care for autism-related disorders?
Knowledge-focused Recruiting nowThis international online study collects medical, behavioral, and developmental information from people with rare genetic changes that are linked to autism and other neurodevelopmental disorders. By partnering with families, researchers aim to build a detailed database to improve…
Sponsor: Simons Searchlight • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
A single blood test may reveal whether a gene tied to transplant outcomes influences psoriatic arthritis risk.
Knowledge-focused Recruiting nowThis study compares the prevalence of the HLA B leader gene in 658 people with psoriatic arthritis and a healthy control group. Researchers will also look at the related HLA B27 gene. The goal is to see whether this genetic marker, already known to affect outcomes in bone marrow …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can a single drink reveal how alcohol triggers oral cancer?
Knowledge-focused Recruiting nowThis study investigates how acetaldehyde, a byproduct of alcohol, affects cells in the mouth and whether it may increase oral cancer risk. Healthy volunteers and individuals with Fanconi anemia (a condition linked to higher cancer risk) will consume a single dose of alcohol and p…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Brain oxygen showdown: nasal cannula vs face mask during sedation
Knowledge-focused Recruiting nowThis study compares two ways of giving oxygen during sedation for medical procedures done outside the operating room: high-flow nasal oxygen and a standard face mask. Researchers measure brain oxygen levels continuously to see which method keeps the brain better oxygenated. One h…
Phase: NA • Sponsor: Firat University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Could your gums be causing your neck pain? scientists investigate
Knowledge-focused Recruiting nowThis study examines a possible connection between gum disease and chronic neck pain. Researchers will compare neck pain intensity and daily disability among adults aged 30-55 with healthy gums, gingivitis, or periodontitis. Participants complete pain scales and questionnaires to …
Sponsor: Nigde Omer Halisdemir University • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Gene mapping of childhood blood cancers could unlock personalized treatments
Knowledge-focused Recruiting nowThis research study collects and analyzes blood and bone marrow samples from children and young adults with leukemia, myelodysplastic syndrome, or myeloproliferative syndrome. By reading the genetic instructions in these cancer cells, scientists hope to understand why the disease…
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Can a simple test predict when smell returns?
Knowledge-focused Recruiting nowThis study follows 30 people with chronic sinusitis and nasal polyps who are starting dupilumab, a medication that can help restore smell. Researchers want to see if the degree of nasal blockage or specific electrical signals from the brain can predict who will regain their sense…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Blood test may predict knee osteoarthritis severity
Knowledge-focused Recruiting nowThis study examines whether two substances in the blood, Fetuin-A and COMP, are linked to the severity of knee osteoarthritis. Researchers will compare 120 people with knee osteoarthritis to 60 healthy volunteers, measuring their pain, mobility, and joint damage on X-rays. The go…
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Saliva test could spot hidden links between diabetes and gum disease
Knowledge-focused Recruiting nowThis study measures four specific substances in saliva—apelin, chemerin, ghrelin, and lipocalin 2—in people with and without type 2 diabetes and gum disease. Researchers want to see if these substances are linked to the presence or severity of these conditions. The goal is to fin…
Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC